J. Bourhis

R. Steenbakkers, M. V. van Herk, V. Grégoire, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Cross-resistance to ionizing radiation in a murine leukemic cell line resistant to cis-dichlorodiammineplatinum(II): role of Ku autoantigen.

J. Bourhis, P. Frit, E. Marangoni, 1999, Molecular pharmacology.

Tirapazamine, cisplatin, and radiation versus cisplatin and radiation for advanced squamous cell carcinoma of the head and neck (TROG 02.02, HeadSTART): a phase III trial of the Trans-Tasman Radiation Oncology Group.

R. Fisher, J. Bourhis, B. O'Sullivan, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy.

A. Garden, K. Ang, M. Chambers, 2004, International journal of radiation oncology, biology, physics.

Serum 2-Hydroxyglutarate Level Can Predict IDH2 Mutation in Myeloid Sarcoma

J. Bourhis, S. Broutin, A. Paci, 2015 .

Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02.

Brian O'Sullivan, Jacques Bernier, Richard Fisher, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis.

M. Parmar, J. Pignon, V. Grégoire, 2017, The Lancet. Oncology.

Osteopontin is upregulated by BCR-ABL.

S. Flamant, J. Bourhis, W. Vainchenker, 2005, Biochemical and biophysical research communications.

Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

Laurence Zitvogel, Sebastian Amigorena, Antoine Tesniere, 2007, Nature Medicine.

Myeloid and lymphoid chimerism after T-cell-depleted bone marrow transplantation: evaluation of conditioning regimens using the polymerase chain reaction to amplify human minisatellite regions of genomic DNA.

J. Bourhis, L. Barnett, S. Mackinnon, 1992, Blood.

J. Bourhis, L. Barnett, S. Mackinnon, 1992 .

Relapse risk after autologous transplantation in patients with newly diagnosed myeloma is not related with infused tumor cell load and the outcome is not improved by CD34+ cell selection: long term follow-up of an EBMT phase III randomized study.

G. Salles, H. Goldschmidt, J. Bourhis, 2007, Haematologica.

Analysis of the treatment plan evaluation process in radiotherapy through eye tracking.

Kristoffer Petersson, François Bochud, Mahmut Ozsahin, 2017, Zeitschrift fur medizinische Physik.

[Individual patient data meta-analyses of randomized trials for the treatment of non-metastatic head and neck squamous cell carcinomas: Principles, results and perspectives].

J. Pignon, J. Bourhis, S. Michiels, 2015, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission.

J. Bourhis, H. Dombret, D. Olive, 2012, Blood.

Overview of the predictive value of quantitative 18 FDG PET in head and neck cancer treated with chemoradiotherapy.

J Castelli, A Depeursinge, John O. Prior, 2016, Critical reviews in oncology/hematology.

Reirradiation in squamous cell head and neck cancer: recent developments and future directions

J. Bourhis, J. Langendijk, 2007, Current opinion in oncology.

The Decreased Susceptibility of Bcr/Abl Targets to NK Cell-Mediated Lysis in Response to Imatinib Mesylate Involves Modulation of NKG2D Ligands, GM1 Expression, and Synapse Formation1

J. Bourhis, S. Chouaib, A. Turhan, 2006, The Journal of Immunology.

Cytolytic function and survival of natural killer cells are severely altered in myelodysplastic syndromes

J. Bourhis, P. Fenaux, S. Chouaib, 2006, Leukemia.

Approach to oligometastatic disease in head and neck cancer, on behalf of the GORTEC.

J. Bourhis, E. Babin, J. Thariat, 2018, Future oncology.

Imaging in Hepatic Veno-occlusive Disease/Sinusoidal Obstruction Syndrome.

Sherwin S. Chan, J. Bourhis, F. Ravaioli, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The Aurora B kinase inhibitor AZD1152 sensitizes cancer cells to fractionated irradiation and induces mitotic catastrophe

P. Opolon, J. Bourhis, G. Kroemer, 2009, Cell cycle.

A Ku80 fragment with dominant negative activity imparts a radiosensitive phenotype to CHO-K1 cells.

P. Jeggo, J. Bourhis, J. Bernier, 2000, Nucleic acids research.

Stereotactic Radiotherapy for the Management of Refractory Ventricular Tachycardia: Promise and Future Directions

J. Bourhis, J. Schwitter, M. Zeverino, 2020, Frontiers in Cardiovascular Medicine.

287 Requirements for the use of an atlas-based automatic segmentation for delineation of Organs at risk (OAR) in conformal radiotherapy (CRT): quality assurance (QA) and preliminary results for 22 adult patients with primary brain tumors

A. Isambert, J. Bourhis, P. Bondiau, 2005 .

Concomitant radiochemotherapy or accelerated radiotherapy: analysis of two randomized trials of the French Head and Neck Cancer Group (GORTEC).

G. Calais, J. Bourhis, C. Sire, 2004, Seminars in oncology.

The efficacy and toxicity of EGFR in the settings of radiotherapy: Focus on published clinical trials.

C. Haie-meder, N. Magné, Cyrus Chargari, 2008, European journal of cancer.

A treatment planning comparison of contemporary photon-based radiation techniques for breast cancer

J. Bourhis, F. Bochud, M. Zeverino, 2018, Physics and imaging in radiation oncology.

Transfer of Ku86 RNA antisense decreases the radioresistance of human fibroblasts

J. Bourhis, J. Bernier, M. Barrois, 2000, Cancer Gene Therapy.

Improving the Outcome of Leukemia by Natural Killer Cell-Based Immunotherapeutic Strategies

J. Bourhis, S. Chouaib, J. Spanholtz, 2014, Front. Immunol..

Monitoring translocations by M-FISH and three-color FISH painting techniques: a study of two radiotherapy patients.

J. Bourhis, A. Giraudet, P. Voisin, 2007, Journal of radiation research.

Enhancement of IUdR Radiosensitization by Low-Energy Photons Results from Increased and Persistent DNA Damage

J. Bourhis, J. Ravanat, E. Deutsch, 2017, PloS one.

Altered natural killer cell differentiation in CD34+ progenitors from Chronic Myeloid Leukemia patients

J. Bourhis, S. Chouaib, L. Castagna, 2000, Oncogene.

Quantified relationship between cellular radiosensitivity, DNA repair defects and chromatin relaxation: a study of 19 human tumour cell lines from different origin.

J. Bourhis, N. Chavaudra, N. Foray, 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Correction to: Neoadjuvant chemoradiotherapy delivered with helical tomotherapy under daily image guidance for rectal cancer patients: efficacy and safety in a large, multi-institutional series

J. Bourhis, M. Zeverino, M. Montemurro, 2019, Journal of Cancer Research and Clinical Oncology.

Treatment with piperacillin-tazobactam and false-positive Aspergillus galactomannan antigen test results for patients with hematological malignancies.

J. Bourhis, A. Aupérin, E. Chachaty, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial.

V. Grégoire, G. Calais, J. Bourhis, 2012, The Lancet. Oncology.

BCR-ABL down-regulates the DNA repair protein DNA-PKcs.

J. Bourhis, W. Vainchenker, L. Maggiorella, 2001, Blood.

Mesenchymal cells generated from patients with myelodysplastic syndromes are devoid of chromosomal clonal markers and support short- and long-term hematopoiesis in vitro

S. Flamant, J. Bourhis, A. Bernheim, 2005, Oncogene.

Effect of amifostine on survival among patients treated with radiotherapy: a meta-analysis of individual patient data.

J. Pignon, P. Levendag, J. Bourhis, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A randomized study of very accelerated radiotherapy with and without amifostine in head and neck squamous cell carcinoma.

R. Crevoisier, J. Bourhis, E. Deutsch, 2000, International journal of radiation oncology, biology, physics.

Optimization of re-irradiation using deformable registration: a case study

J. Bourhis, R. Moeckli, N. Péguret, 2016, BJR case reports.

Antiviral agent Cidofovir restores p53 function and enhances the radiosensitivity in HPV-associated cancers

J. Bourhis, W. Vainchenker, L. Maggiorella, 2002, Oncogene.

Meta-analysis of chemotherapy in head and neck cancer: individual patient data vs literature data.

J. Pignon, J. Bourhis, 1995, British Journal of Cancer.

Long-term Outcome and Late Side Effects in Endometrial Cancer Patients Treated with Surgery and Postoperative Radiation Therapy

J. Bourhis, M. Ozsahin, C. Achtari, 2014, Annals of Surgical Oncology.

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients.

J. Pignon, J. Bourhis, E. Maillard, 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Hyperfractionated or accelerated radiotherapy for head and neck cancer.

K. Ang, J. Horiot, J. Pignon, 2010, The Cochrane database of systematic reviews.

Sensitivity to Radiation and Alkylating Agent of Peripheral Lymphocytes and Fibroblasts in a Hoyeraal-Hreidarsson Syndrome Patient

J. Bourhis, A. Valent, A. Bernheim, 2003, Pediatric hematology and oncology.

A potential graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: results from the French Bone Marrow Transplantation Society

J. Bourhis, H. Dombret, A. Baruchel, 2003, Bone Marrow Transplantation.

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site.

J. Pignon, J. Bourhis, P. Blanchard, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

2603 : Caspase-Independence of Radioinduced Cell Death in Hct116 Human Colorectal Tumor Cell Lines

J. Bourhis, G. Kroemer, E. Deutsch, 2006 .

Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma.

V. Grégoire, J. Bourhis, M. Hamoir, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[Intensity modulation in breast radiotherapy: development of an innovative field-in-field technique at Institut Gustave-Roussy].

J. Bourhis, D. Lefkopoulos, H. Marsiglia, 2011, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

High dose‐per‐pulse electron beam dosimetry: Commissioning of the Oriatron eRT6 prototype linear accelerator for preclinical use

J. Bourhis, F. Bochud, M. Jaccard, 2018, Medical physics.

Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients.

J. Bourhis, S. Koscielny, J. Armand, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Proton therapy for head and neck squamous cell carcinomas: A review of the physical and clinical challenges.

J. Bourhis, M. Vidal, J. Thariat, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Radiotherapy combination opportunities leveraging immunity for the next oncology practice

G. Coukos, J. Bourhis, F. Herrera, 2017, CA: a cancer journal for clinicians.

A delivery quality assurance tool based on the actual leaf open times in tomotherapy.

J. Bourhis, F. Bochud, R. Moeckli, 2020, Medical physics.

Enhancement of radiation response by inhibition of Aurora-A kinase using siRNA or a selective Aurora kinase inhibitor PHA680632 in p53-deficient cancer cells

J. Bourhis, E. Deutsch, V. Frascogna, 2007, British Journal of Cancer.

Early side effects of three-dimensional conformal external beam accelerated partial breast irradiation to a total dose of 40 Gy in one week (a phase II trial).

J. Bourhis, A. Taghian, M. Mathieu, 2011, International journal of radiation oncology, biology, physics.

[Accelerated partial breast irradiation: bifractionated 40Gy in one week. A French pilot phase II study].

J. Bourhis, A. Taghian, M. Mathieu, 2010, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Induction of CTGF by TGF-beta1 in normal and radiation enteritis human smooth muscle cells: Smad/Rho balance and therapeutic perspectives.

J. Bourhis, C. Bourgier, J. Aigueperse, 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Influence of endothelial cells on vascular smooth muscle cells phenotype after irradiation: implication in radiation-induced vascular damages.

J. Bourhis, P. Validire, E. Deutsch, 2006, The American journal of pathology.

Early-stage Favourable Anal Cancer: A Retrospective Analysis of Clinical Outcomes of a Moderately Low Dose Elective Nodal Intensity-modulated Radiotherapy Schedule.

J. Bourhis, R. Miralbell, M. Ozsahin, 2017, Clinical oncology (Royal College of Radiologists (Great Britain)).

Environmental, genetic, and molecular features of prostate cancer.

J. Bourhis, J. Soria, L. Maggiorella, 2004, The Lancet. Oncology.

Scoring System Based on Post-Transplant Complications in Patients after Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome: A Study from the SFGM-TC.

J. Bourhis, M. Robin, P. Chevallier, 2019, Current research in translational medicine.

Comparison of Intensive Chemotherapy and Hypomethylating Agents before Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndromes: A Study of the Myelodysplastic Syndrome Subcommittee of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplant R

J. Bourhis, G. Mufti, N. Kröger, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Clofarabine versus fludarabine‐based reduced‐intensity conditioning regimen prior to allogeneic transplantation in adults with AML/MDS

J. Bourhis, M. Labopin, P. Chevallier, 2016, Cancer medicine.

Successful mitigation of delayed intestinal radiation injury using pravastatin is not associated with acute injury improvement or tumor protection.

J. Bourhis, C. Bourgier, J. Aigueperse, 2007, International journal of radiation oncology, biology, physics.

Concurrent use of cisplatin or cetuximab with definitive radiotherapy for locally advanced head and neck squamous cell carcinomas

J. Bourhis, E. Deutsch, F. Janot, 2014, Strahlentherapie und Onkologie.

Individual patients' data meta-analyses in head and neck cancer

J. Pignon, J. Bourhis, A. le Maître, 2007, Current opinion in oncology.

Predictive classifier for intensive treatment of head and neck cancer

M. Parmar, J. Pignon, V. Grégoire, 2020, Cancer.

Treatment deintensification and symptom burden in patients with human papillomavirus‐associated head and neck cancer

J. Bourhis, M. Ozsahin, 2015, Cancer.

(18F)-FDG PET/CT parameters to predict survival and recurrence in patients with locally advanced cervical cancer treated with chemoradiotherapy.

John O. Prior, J. Bourhis, A. Depeursinge, 2018, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Sparing healthy lung by focusing the radiation beam flow onto the emphysematous regions in the treatment of lung cancer

J. Bourhis, C. Beigelman-Aubry, R. Moeckli, 2017, Journal of medical imaging and radiation oncology.

Inhibition of BCL-2 in small cell lung cancer cell lines with oblimersen, an antisense BCL-2 oligodeoxynucleotide (ODN): in vitro and in vivo enhancement of radiation response.

J. Bourhis, J. Soria, P. Mordant, 2010, Anticancer research.

Prolonged Apnea Supported by High-Frequency Noninvasive Ventilation: A Pilot Study.

J. Bourhis, R. Heinzer, N. Péguret, 2017, American journal of respiratory and critical care medicine.

Chromosomal aberrations induced by chemotherapy and radiotherapy in lymphocytes from patients with breast carcinoma.

J. Bourhis, N. Chavaudra, F. Eschwège, 2002, International journal of radiation oncology, biology, physics.

Cetuximab, docetaxel, and cisplatin as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, phase II GORTEC study.

J. Bourhis, J. Machiels, C. Sire, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell Malignancies

J. Bourhis, N. Kröger, P. Chevallier, 2021, Frontiers in Immunology.

Long-term outcomes after reduced-intensity conditioning allogeneic stem cell transplantation for low-grade lymphoma: a survey by the French Society of Bone Marrow Graft Transplantation and Cellular Therapy (SFGM-TC).

R. Porcher, J. Bourhis, H. Tilly, 2007, Haematologica.

What have we learned from human papillomavirus-positive tumors? Trying to connect data about biomarkers among human papillomavirus-related squamous cell carcinomas.

J. Bourhis, E. Deutsch, M. Vozenin, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Antiviral approaches for cancers related to Epstein-Barr virus and human papillomavirus.

J. Bourhis, B. Abdulkarim, 2001, The Lancet. Oncology.

Radiotherapy with concomitant weekly docetaxel for Stages III/IV oropharynx carcinoma. Results of the 98-02 GORTEC Phase II trial.

G. Calais, J. Bourhis, C. Sire, 2004, International journal of radiation oncology, biology, physics.

Advances in radiotherapy of head and neck cancers

J. Bourhis, N. Daly-Schveitzer, Y. Tao, 2010, Current opinion in oncology.

Cooperative effect of roscovitine and irradiation targets angiogenesis and induces vascular destabilization in human breast carcinoma

P. Opolon, E. Connault, J. Bourhis, 2009, Cell proliferation.

PROTECTIVE EFFECT OF OESTROGEN IN PANCREATIC CANCER

J. Bourhis, F. Lacaine, M. Huguier, 1987, The Lancet.

High versus low dose irradiation for tumor immune reprogramming.

G. Coukos, J. Bourhis, F. Herrera, 2020, Current opinion in biotechnology.

New approaches to enhance chemotherapy in SCCHN.

J. Bourhis, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Chronic myeloid leukemia and allogeneic natural killer cells: a surprising dialogue

J. Bourhis, A. Caignard, S. Wittnebel, 2006, Expert review of clinical immunology.

Altered IFNgamma signaling and preserved susceptibility to activated natural killer cell-mediated lysis of BCR/ABL targets.

J. Bourhis, S. Chouaib, I. Voutsadakis, 2005, Cancer research.

Maintenance therapy with thalidomide improves survival in patients with multiple myeloma.

Serge Leyvraz, Herve Avet-Loiseau, Philippe Moreau, 2006, Blood.

Hypofractionated FLASH-RT as an Effective Treatment against Glioblastoma that Reduces Neurocognitive Side Effects in Mice

J. Bourhis, F. Bochud, R. Moeckli, 2020, Clinical Cancer Research.

Pravastatin Inhibits the Rho/CCN2/Extracellular Matrix Cascade in Human Fibrosis Explants and Improves Radiation-Induced Intestinal Fibrosis in Rats

J. Bourhis, M. Pocard, C. Bourgier, 2007, Clinical Cancer Research.

An unusual cause of upper gastrointestinal haemorrhage

J. Bourhis, F. Milliat, C. Bourgier, 2005, Gut.

The radiosensitizing activity of the SMAC-mimetic, Debio 1143, is TNFα-mediated in head and neck squamous cell carcinoma.

J. Bourhis, G. Vuagniaux, N. Wiedemann, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Phase III randomized trial of very accelerated radiation therapy compared with conventional radiation therapy in squamous cell head and neck cancer: a GORTEC trial.

J. Bourhis, P. Verrelle, C. Lemanski, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gallium scan in the evaluation of post chemotherapy mediastinal residual masses of aggressive non-Hodgkin's lymphoma.

J. Bourhis, P. Dartevelle, S. Koscielny, 1999, Leukemia & lymphoma.

Radiotherapy options after breast-conserving surgery: how can selection of patients be refined?

J. Bourhis, M. Ozsahin, J. Delaloye, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic value of the age-adjusted International Prognostic Index in chemosensitive recurrent or refractory non-Hodgkin's lymphomas treated with high-dose BEAM therapy and autologous stem cell transplantation

J. Bourhis, S. Koscielny, V. Ribrag, 2005, Leukemia & lymphoma.

Retrospective analysis of the impact of respiratory motion in treatment margins for frameless lung SBRT based on respiratory‐correlated CBCT data‐sets

J. Bourhis, D. Racine, F. Bochud, 2020, Journal of applied clinical medical physics.

OC-0138: Apnea-like suppression of respiratory motion: first clinical evaluation

John O. Prior, Kathleen M. Grant, R. Meuli, 2016 .

Apnea-like suppression of respiratory motion: First evaluation in radiotherapy.

John O. Prior, Kathleen M. Grant, J. Bourhis, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Can Segmentectomy Still Be Proposed As an Alternative to Lobectomy in 2016?

J. Bourhis, M. Ozsahin, B. De Bari, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Thrombotic microangiopathy: a new dose-limiting toxicity of high-dose sequential chemotherapy

J. Bourhis, P. Fenaux, V. Ribrag, 2001, Bone Marrow Transplantation.

Antiviral agent Cidofovir decreases Epstein–Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies

D. Zélénika, J. Bourhis, J. Klijanienko, 2003, Oncogene.

Reproductive Viability of Cells Following Preoperative Stereotactic Ablative Radiotherapy.

J. Bourhis, B. Slotman, M. Ozsahin, 2019, International journal of radiation oncology, biology, physics.

Radiotherapy-chemotherapy combinations in head and neck squamous cell carcinoma: overview of randomized trials.

J. Bourhis, F. Eschwège, Jean Bourhis, 1996, Anticancer research.

Chemotherapy as an adjunct to radiotherapy in locally advanced nasopharyngeal carcinoma.

J. Pignon, J. Bourhis, S. Leung, 2006, The Cochrane database of systematic reviews.

Expression, and Synapse Formation Modulation of NKG2D Ligands, GM1 Response to Imatinib Mesylate Involves Targets to NK Cell-Mediated Lysis in The Decreased Susceptibility of Bcr/Abl

J. Bourhis, S. Chouaib, A. Turhan, 2005 .

Atlas-based automatic segmentation (ABAS) of head structures in conformal radiation therapy (CRT): atlas development and preliminary results in clinical context

Grégoire Malandain, Olivier Commowick, John A. Mills, 2007 .

Global gene expression profiles reveal an increase in mRNA levels of collagens, MMPs, and TIMPs in late radiation enteritis.

J. Bourhis, F. Milliat, M. Vozenin-Brotons, 2004, American journal of physiology. Gastrointestinal and liver physiology.

Postoperative Adjuvant Lapatinib and Concurrent Chemoradiotherapy Followed by Maintenance Lapatinib Monotherapy in High-Risk Patients With Resected Squamous Cell Carcinoma of the Head and Neck: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study.

J. Bourhis, K. Harrington, G. Manikhas, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Surveillance of Aspergillus galactomannan antigenemia for invasive aspergillosis by enzyme-linked immunosorbent assay in neutropenic patients treated for hematological malignancies.

J. Bourhis, P. Fenaux, A. Ulusakarya, 2000, The hematology journal : the official journal of the European Haematology Association.

n-3 Polyunsaturated fatty acids decrease mucosal/epidermal reactions and enhance antitumour effect of ionising radiation with inhibition of tumour angiogenesis

P. Opolon, E. Connault, J. Bourhis, 2003, British Journal of Cancer.

Dissociated responses to newer antimyeloma drugs identify a subset of refractory patients with an extremely poor prognosis.

F. Pasquier, J. Bourhis, X. Mariette, 2013, European journal of cancer.

Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by radiation therapy: results of a retrospective study of 386 patients.

A. Gerbaulet, J. Bourhis, J. Cosset, 1989, International journal of radiation oncology, biology, physics.

Altered fractionated radiotherapy in the management of head and neck carcinomas: advantages and limitations

J. Pignon, G. Calais, J. Bourhis, 2004, Current opinion in oncology.

Monitoring antibiotic-resistant enterobacteria faecal levels is helpful in predicting antibiotic susceptibility of bacteraemia isolates in patients with haematological malignancies.

F. Pasquier, J. Bourhis, S. de Botton, 2015, Journal of medical microbiology.

The Advantage of FLASH Radiotherapy Confirmed in Mini-pig and Cat-cancer Patients

J. Bourhis, F. Bochud, M. Jaccard, 2018, Clinical Cancer Research.

Ex vivo expansion of megakaryocyte precursor cells in autologous stem cell transplantation for relapsed malignant lymphoma

J. Bourhis, M. Guillier, S. Assari, 2004, Bone Marrow Transplantation.

Predictive classifier for intensive treatment of head and neck cancer

M. Parmar, J. Pignon, V. Grégoire, 2020, Cancer.

Detection of chimerism in subpopulations of cells by fluorescence in situ hybridization and immunofluorescent staining of cell surface antigens.

J. Bourhis, W. Gerritsen, C. Jagiello, 1994, Bone marrow transplantation.

Should we include SPECT lung perfusion in radiotherapy treatment plans of thoracic targets? Evidences from the literature.

John O. Prior, J. Bourhis, M. Ozsahin, 2016, Critical reviews in oncology/hematology.

Telomere shortening: a new prognostic factor for cardiovascular disease post-radiation exposure.

J. Bourhis, M. Ricoul, L. Sabatier, 2015, Radiation protection dosimetry.

Radioprotective effect of amifostine in patients with head and neck squamous cell carcinoma.

J. Bourhis, D. Rosine, 2002, Seminars in oncology.

Randomized phase III trial (GORTEC 98-03) comparing re-irradiation plus chemotherapy versus methotrexate in patients with recurrent or a second primary head and neck squamous cell carcinoma, treated with a palliative intent.

G. Calais, J. Bourhis, P. Maingon, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Concurrent cisplatin and Dose escalation with Intensity-modulated radiotherapy (IMRT) versus conventional radiotherapy for locally advanced head and neck squamous cell carcinomas (HNSCC): GORTEC 2004-01 randomized phase III trial.

J. Bourhis, J. Thariat, J. Castelli, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients: matched-pair comparison with conventional radiotherapy.

J. Bourhis, P. Giraud, P. Maingon, 2007, International journal of radiation oncology, biology, physics.

[Individual patient data meta-analyses in head and neck carcinoma: what have we learnt?].

J. Pignon, J. Bourhis, B. Baujat, 2005, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Chest-MRI under pulsatile flow ventilation: A new promising technique

Kathleen M. Grant, R. Meuli, M. Stuber, 2017, PloS one.

A phase I trial combining oral cisplatin (CP Ethypharm) with radiotherapy in patients with locally advanced head and neck squamous cell carcinoma.

J. Bourhis, S. Urien, N. Daly-Schveitzer, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A radiation recall phenomenon induced by aromatase inhibitors

J. Bourhis, W. Jeanneret-Sozzi, P. Tsoutsou, 2020 .

Effect of priming with granulocyte–macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) Group

J. Bourhis, H. Dombret, B. Quesnel, 2007, Leukemia.

Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial.

J. Bourhis, C. Sire, A. Aupérin, 2021, The Lancet. Oncology.

Hyperfractionated or accelerated radiotherapy for head and neck cancer.

K. Ang, J. Horiot, J. Pignon, 2010 .

Tumor-infiltrating lymphocytes in triple-negative breast cancer: a biomarker for use beyond prognosis?

G. Coukos, J. Bourhis, P. Tsoutsou, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Influence of endothelial cells on vascular smooth muscle cells phenotype after irradiation: implication in radiation-induced vascular damages.

J. Bourhis, P. Validire, E. Deutsch, 2006, The American journal of pathology.

Antilymphocyte globulin for matched sibling donor transplantation in patients with myelofibrosis

J. Bourhis, N. Kröger, C. Craddock, 2019, Haematologica.

Bio-radiation dermatitis: the need of a new grading: in regard to Bernier et al: Ann Oncol 2011; 22(10): 2191-2200.

J. Bourhis, M. Lacouture, R. Corvò, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Successful treatment of severe post hematopoietic stem cell transplantation bronchiolitis obliterans syndrome with lung transplantation in a patient with multi‐organ chronic graft‐versus‐host disease

F. Jardin, J. Bourhis, A. Stamatoullas, 2022, Clinical Case Reports.

Radiation‐induced expression of functional Fas ligand in EBV‐positive human nasopharyngeal carcinoma cells

J. Bourhis, W. Vainchenker, E. Deutsch, 2000, International journal of cancer.

Autologous stem cell transplantation after first remission induction treatment in multiple myeloma: a report of the French Registry on autologous transplantation in multiple myeloma.

J. Bourhis, V. Leblond, G. Marit, 1995, Blood.

Phase II Trial of Irinotecan (CPT-11) in Relapsed or Refractory Non-Hodgki n's Lymphomas

J. Bourhis, S. Koscielny, V. Ribrag, 2003, Leukemia & lymphoma.

Baseline and treatment-induced chromosomal abnormalities in peripheral blood lymphocytes of Hodgkin's lymphoma patients.

J. Bourhis, S. Koscielny, A. Bernheim, 2003, International journal of radiation oncology, biology, physics.

Avelumab and cetuximab as a therapeutic combination: An overview of scientific rationale and current clinical trials in cancer.

J. Becker, J. Bourhis, F. Ciardiello, 2021, Cancer treatment reviews.

Phase I study of cetuximab in combination with cisplatin or carboplatin and 5-fluorouracil (5-FU) in patients (pts) with recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN).

J. Bourhis, C. Borel, Y. Humblet, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Distant Metastasis of Undifferentiated Carcinoma of Nasopharyngeal Type

F. Bidault, J. Bourhis, J. Bosq, 2008, Oncology Research and Treatment.

A retrospective, matched paired analysis comparing bendamustine containing BeEAM versus BEAM conditioning regimen: results from a single center experience

J. Bourhis, S. Koscielny, V. Ribrag, 2018, Leukemia & lymphoma.

Mobilization of peripheral blood progenitor cells after DHAP regimen with or without rituximab: A large multicenter comparative study in patients with malignant lymphoma

J. Bourhis, O. Legrand, Sophie Park, 2007, Leukemia & lymphoma.

Comparison of high-dose cytarabine and timed-sequential chemotherapy as consolidation for younger adults with AML in first remission: the ALFA-9802 study.

J. Bourhis, H. Dombret, B. Quesnel, 2011, Blood.

Leukemic stem cell persistence in chronic myeloid leukemia patients in deep molecular response induced by tyrosine kinase inhibitors and the impact of therapy discontinuation

J. Bourhis, A. Bennaceur-Griscelli, P. Rousselot, 2016, Oncotarget.

A randomized trial of induction docetaxel–cisplatin–5FU followed by concomitant cisplatin-RT versus concomitant cisplatin-RT in nasopharyngeal carcinoma (GORTEC 2006-02)

J. Bourhis, J. Thariat, N. Toumi, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II trial of CPT-11 in myelodysplastic syndromes with excess of marrow blasts

J. Bourhis, P. Fenaux, V. Ribrag, 2003, Leukemia.

Prognostic value of a new clinically-based classification system in patients with CMML undergoing allogeneic HCT: a retrospective analysis of the EBMT-CMWP

A. Ganser, J. Bourhis, S. Iacobelli, 2022, Bone Marrow Transplantation.

Clofarabine/busulfan-based reduced intensity conditioning regimens provides very good survivals in acute myeloid leukemia patients in complete remission at transplant: a retrospective study on behalf of the SFGM-TC

J. Bourhis, M. Labopin, P. Chevallier, 2018, Oncotarget.

High numbers of mobilized CD34+ cells collected in AML in first remission are associated with high relapse risk irrespective of treatment with autologous peripheral blood SCT or autologous BMT

J. Bourhis, A. Hagemeijer, M. Vignetti, 2015, Bone Marrow Transplantation.

TRANSPLANTATION Outcome of patients with distinct molecular genotypes and cytogenetically normal AML after allogeneic transplantation Group of Bone Transplantation

J. Esteve, J. Bourhis, F. Baron, 2015 .

Outcome of treatment after first relapse in younger adults with acute myeloid leukemia initially treated by the ALFA-9802 trial.

J. Bourhis, H. Dombret, B. Quesnel, 2012, Leukemia research.

Allogeneic stem cell transplantation for chronic myelomonocytic leukemia: a report from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire

J. Bourhis, M. Bernard, M. Labopin, 2013, European journal of haematology.

Activation of cytotoxic T-cell receptor γδ T lymphocytes in response to specific stimulation in myelodysplastic syndromes

J. Bourhis, S. Chevret, P. Fenaux, 2008, Haematologica.

A case of multicentric Castleman's disease associated with advanced systemic amyloidosis treated with chemotherapy and anti-CD20 monoclonal antibody

J. Bourhis, D. Gholam, J. Vantelon, 2003, Annals of Hematology.

Duplication of the Ph-chromosome as a possible mechanism of resistance to imatinib mesylate in patients with chronic myelogenous leukemia.

J. Bourhis, A. Bernheim, G. Danglot, 2005, Cancer genetics and cytogenetics.

High survival rate with the LMT-89 regimen in lymphoblastic lymphoma (LL), but not in T-cell acute lymphoblastic leukemia (T-ALL)

J. Bourhis, S. Koscielny, P. Biron, 2006, Leukemia.

[Pharmacological modulation of late radio-induced side effects].

J. Bourhis, E. Deutsch, C. Bourgier, 2011, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Randomized trials of amifostine and radiotherapy: effect on survival?

J. Bourhis, K. Thephamongkhol, J. Pignon, 2004, Seminars in oncology.

Legionellosis after hematopoietic stem cell transplantation

J. Bourhis, D. Blaise, C. Crawley, 2021, Bone Marrow Transplantation.

Long-term follow-up of a trial comparing post-remission treatment with autologous or allogeneic bone marrow transplantation or intensive chemotherapy in younger acute myeloid leukemia patients

J. Bourhis, M. Vignetti, F. Baron, 2020, Haematologica.

Randomized Comparison of Standard Induction with Daunorubicin (DNR) for 3 Days vs Idarubicin (IDA) for 3 or 4 Days in AML pts Aged 50 to 70 and of Maintenance with Interleukin 2. Final Analysis of the ALFA 9801 Study.

J. Bourhis, H. Dombret, S. Chevret, 2007 .

Establishment and Characterization of a Reliable Xenograft Model of Hodgkin Lymphoma Suitable for the Study of Tumor Origin and the Design of New Therapies

J. Bourhis, R. Boisgard, J. Bosq, 2018, Cancers.

Percussion assisted radiation therapy in Hodgkin lymphoma allows a marked reduction in heart dose.

J. Bourhis, M. Zeverino, D. Patin, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Regulatory Effect of Recombinant Cytokines on NK Cell Differentiation from Early Marrow Precursors

J. Bourhis, C. Keever, M. V. Gazzola, 1990 .

Allogeneic HCT for adults with B-cell precursor acute lymphoblastic leukemia harboring IKZF1 gene mutations. A study by the Acute Leukemia Working Party of the EBMT

J. Esteve, J. Bourhis, M. Labopin, 2020, Bone Marrow Transplantation.

Early evaluation of natural killer activity in post-transplant acute myeloid leukemia patients

J. Bourhis, S. Chouaib, A. Vataire, 2010, Bone Marrow Transplantation.

Gene Expression Profile in Human Late Radiation Enteritis Obtained by High-Density cDNA Array Hybridization

J. Bourhis, E. Deutsch, F. Milliat, 2004, Radiation research.

Treatment of a first patient with FLASH-radiotherapy.

J. Bourhis, F. Bochud, D. Patin, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Clinical translation of FLASH radiotherapy: Why and how?

J. Bourhis, F. Bochud, R. Moeckli, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

High dose‐per‐pulse electron beam dosimetry — A model to correct for the ion recombination in the Advanced Markus ionization chamber

J. Bourhis, F. Bochud, M. Jaccard, 2017, Medical physics.

Expression of CD94 by ex vivo-differentiated NK cells correlates with the in vitro and in vivo acquisition of cytotoxic features

J. Bourhis, S. Terry, S. Chouaib, 2017, Oncoimmunology.

Enhanced Cytotoxic Activity of Ex Vivo-differentiated Human Natural Killer Cells in the Presence of HOXB4

J. Bourhis, S. Chouaib, C. Pochon, 2014, Journal of immunotherapy.

Hadrontherapy - macrobenefit in cancer therapy?

J. Bourhis, J. Habrand, A. Mazal, 2012 .

NK cells differentiated from bone marrow, cord blood and peripheral blood stem cells exhibit similar phenotype and functions

J. Bourhis, S. Chouaib, A. Bennaceur-Griscelli, 1998, European journal of immunology.

Salvage surgery after concomitant chemoradiation in head and neck squamous cell carcinomas—Stratification for postsalvage survival

J. Bourhis, F. Janot, A. Aupérin, 2009, Head & neck.

Very accelerated radiotherapy or concurrent chemoradiotherapy for N3 head and neck squamous cell carcinoma: Pooled analysis of two GORTEC randomized trials.

V. Grégoire, G. Calais, J. Bourhis, 2017, Oral oncology.

Feasibility of radiotherapy or chemoradiotherapy after taxane-based induction chemotherapy for nonoperated locally advanced head and neck squamous cell carcinomas

J. Bourhis, F. Janot, N. Daly-Schveitzer, 2014, Anti-cancer drugs.

Multimodal treatment and long-term outcome of patients with esthesioneuroblastoma.

J. Bourhis, F. Janot, N. Daly-Schveitzer, 2013, Oral oncology.

Phase I trial of oral etoposide in combination with radiotherapy in head and neck squamous cell carcinoma - GORTEC 2004–02

J. Bourhis, N. Daly-Schveitzer, Y. Tao, 2013, Radiation oncology.

Definitive radiotherapy for squamous cell carcinoma of the pyriform sinus.

J. Bourhis, F. Janot, N. Daly-Schveitzer, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Modified fractionated radiotherapy in head and neck squamous cell carcinoma (HNSCC) & re-irradiation in recurrent head and neck carcinomas.

J. Bourhis, F. Eschwège, R. de Crevoisier, 2003, Cancer treatment and research.

Quantitative analysis of T helper 1, T helper 2, and inflammatory cytokine expression in patients after allogeneic bone marrow transplantation: relationship with the occurrence of acute graft-versus-host disease.

J. Bourhis, J. Bosq, S. Chouaib, 1997, Transplantation.

Benefits of chemotherapy in head and neck cancer

J. Pignon, J. Bourhis, C. Hill, 2000, The Lancet.

Interfractional set-up errors evaluation by daily electronic portal imaging of IMRT in head and neck cancer patients

R. Arriagada, J. Bourhis, D. Lefkopoulos, 2009, Acta oncologica.

Hepatocyte growth factor/scatter factor (HGF/SF) affects proliferation and migration of myeloid leukemic cells

T. Nakamura, J. Bourhis, C. Voermans, 1998, Leukemia.

Assessment of the novel tubulin-binding agent EHT 6706 in combination with ionizing radiation or chemotherapy

J. Bourhis, E. Deutsch, A. Casagrande, 2012, Investigational New Drugs.

Reply to D. Tural et al.

J. Pignon, J. Bourhis, P. Blanchard, 2014, Journal of Clinical Oncology.

Taxane-cisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta-analysis of the meta-analysis of chemotherapy in head and neck cancer group.

Pierre Blanchard, Gilles Calais, Jean Bourhis, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Squamous cell carcinoma of the larynx with subglottic extension: is larynx preservation possible?

F. Bidault, J. Bourhis, F. Janot, 2014, Strahlentherapie und Onkologie.

Extensive chronic GVHD is associated with donor blood CD34+ cell count after G-CSF mobilization in non-myeloablative allogeneic PBSC transplantation

J. Bourhis, D. Blaise, P. Tiberghien, 2012, Bone Marrow Transplantation.

A randomized study of very accelerated radiotherapy with and without amifostine in head and neck squamous cell carcinoma

R. Crevoisier, J. Bourhis, V. Georgoulias, 2001 .

Limited efficacy and tolerance of imatinib mesylate in steroid-refractory sclerodermatous chronic GVHD.

J. Bourhis, M. Robin, M. Rybojad, 2012, Blood.

Role of chemotherapy in 5000 patients with head and neck cancer treated by curative surgery: A subgroup analysis of the meta-analysis of chemotherapy in head and neck cancer.

J. Pignon, V. Grégoire, J. Bourhis, 2019, Oral oncology.

Accelerated radiotherapy and concomitant high dose chemotherapy in non resectable stage IV locally advanced HNSCC: results of a GORTEC randomized trial.

J. Bourhis, F. Janot, P. Blanchard, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

non-T-cell- depleted bone marrow transplantation frequent survival of residual recipient multipotent progenitors after Highly sensitive polymerase chain reaction methods show the

J. Bourhis, G. Socié, E. Gluckman, 2011 .

The c-myc proto-oncogene in invasive carcinomas of the uterine cervix: clinical relevance of overexpression in early stages of the cancer.

J. Bourhis, G. Riou, M. Lê, 1990, Anticancer research.

New trends in radiotherapy for head and neck cancer.

J. Bourhis, A. Lusinchi, A. Etessami, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Antithymocyte globulins and chronic graft-vs-host disease after myeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors: a report from the Sociéte Française de Greffe de Moelle et de Thérapie Cellulaire

J. Bourhis, M. Labopin, I. Yakoub-Agha, 2010, Leukemia.

[Normal tissue tolerance to external beam radiation therapy: larynx and pharynx].

G. Calais, J. Bourhis, C. Lafond, 2010, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Fibrogenic signals in patients with radiation enteritis are associated with increased connective tissue growth factor expression.

C. Haie-meder, J. Bourhis, F. Milliat, 2003, International journal of radiation oncology, biology, physics.

Induction Chemotherapy Followed by Cetuximab Radiotherapy Is Not Superior to Concurrent Chemoradiotherapy for Head and Neck Carcinomas: Results of the GORTEC 2007-02 Phase III Randomized Trial.

J. Bourhis, E. Babin, C. Borel, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

TAT-RasGAP317–326 Enhances Radiosensitivity of Human Carcinoma Cell Lines In Vitro and In Vivo through Promotion of Delayed Mitotic Cell Death

J. Bourhis, C. Widmann, F. Buchegger, 2017, Radiation Research.

Efficacy of Recombinant Human Interleukin 7 in a Patient With Severe Lymphopenia-Related Progressive Multifocal Leukoencephalopathy

J. Bourhis, O. Lambotte, B. Stankoff, 2014, Open forum infectious diseases.

Phase I trial of tirapazamine, cisplatin, and concurrent accelerated boost reirradiation in patients with recurrent head and neck cancer.

J. Bourhis, E. Vokes, D. Haraf, 2007, International journal of radiation oncology, biology, physics.

Hypoxia response pathways and radiotherapy for head and neck cancer.

J. Bourhis, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

ESTRO 2012 strategy meeting: vision for radiation oncology.

J. Bourhis, V. Valentini, D. Hollywood, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Letter by Jumeau et al Regarding Article, "Phase I/II Trial of Electrophysiology-Guided Noninvasive Cardiac Radioablation for Ventricular Tachycardia".

J. Bourhis, E. Pruvot, R. Jumeau, 2019, Circulation.

Response to Spartalis et al.

J. Bourhis, R. Moeckli, M. Ozsahin, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Inhibition of the human allogeneic mixed lymphocyte response by cyclosporin A: relationship with the IL-12 pathway.

J. Bourhis, B. Bonnotte, F. Mami-Chouaib, 1996, Tissue antigens.

Which AML Subsets Benefit from Leukemic Cell Priming during Chemotherapy? Long-Term Analysis of the ALFA-9802 GM-CSF Study

J. Bourhis, H. Dombret, C. Preudhomme, 2008 .

Avelumab-cetuximab-radiotherapy versus standards of care in locally advanced squamous-cell carcinoma of the head and neck: The safety phase of a randomised phase III trial GORTEC 2017-01 (REACH).

J. Bourhis, J. Thariat, C. Sire, 2020, European journal of cancer.

Randomized trial comparing two methods of re-irradiation after salvage surgery in head and neck squamous cell carcinoma: Once daily split-course radiotherapy with concomitant chemotherapy or twice daily radiotherapy with cetuximab.

J. Bourhis, F. Janot, A. Laprie, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Multicenter Randomized Double-Blind, Placebo-Controlled Trial GORTEC (Groupe Oncologie Radiotherapie Tete et Cou) 2009-01 Evaluating the Effect of the Regenerating Agent on Radiodermatitis of Head and Neck Cancer Patients.

J. Bourhis, C. Sire, P. Blanchard, 2017, International journal of radiation oncology, biology, physics.

Retreatment of recurrent head and neck cancer in a previously irradiated field.

J. Bourhis, C. Langer, Stuart J. Wong, 2012, Seminars in radiation oncology.

Conventional vs modified fractionated radiotherapy. meta-analysis of radiotherapy in head & neck squamous cell carcinoma : a meta-analysis based on individual patient data

K. Ang, J. Horiot, J. Pignon, 2002 .

What Is the Best Treatment of Locally Advanced Nasopharyngeal Carcinoma? An Individual Patient Data Network Meta-Analysis.

George Fountzilas, Pierre Blanchard, Anne W M Lee, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

OC-003: What is the best treatment in nasopharyngeal carcinoma? An individual patient data network meta-analysis

Jun Ma, J. Pignon, J. Bourhis, 2015 .

Meta-analysis of chemotherapy in nasopharyngeal carcinoma (MAC-NPC): An update on 4,798 patients.

Jun Ma, J. Pignon, J. Bourhis, 2014 .

[Nasopharyngeal cancers, an overview].

J. Bourhis, J. Thariat, N. Toumi, 2014, Bulletin du cancer.

Nasopharyngeal cancers, an overview on behalf of the French Intergroupe ORL/GORTEC

J. Bourhis, J. Thariat, N. Toumi, 2014 .

Nasopharyngeal carcinoma and therapeutic management: the place of chemotherapy.

J. Bourhis, J. Armand, S. Temam, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Outcome of a Salvage Third Autologous Stem Cell Transplantation in Multiple Myeloma.

H. Goldschmidt, H. Einsele, J. Johansson, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Treatment of the N0 neck during salvage surgery after radiotherapy of head and neck squamous cell carcinoma

J. Bourhis, F. Janot, S. Temam, 2005, Head & neck.

Avelumab-cetuximab-radiotherapy (RT) versus standards of care (SoC) in locally advanced squamous cell carcinoma of the head and neck (SCCHN): Safety phase of the randomized trial GORTEC 2017-01 (REACH).

J. Bourhis, C. Sire, A. Aupérin, 2018 .

Escalating high-dose carboplatin and autologous bone marrow transplantation in solid tumors.

J. Bourhis, J. Droz, L. Castagna, 1993, Oncology.

Clinical significance of multiple drug resistance in human cancers.

J. Bourhis, G. Riou, J. Bénard, 1990, Anticancer research.

Clonality in myelodysplastic syndromes.

J. Bourhis, W. Gerritsen, G. D. de Gast, 1994, Leukemia & lymphoma.

Anti-Ly6G binding and trafficking mediate positive neutrophil selection to unleash the anti-tumor efficacy of radiation therapy

J. Bourhis, E. Meylan, B. Petit, 2021, Oncoimmunology.

Comparison of autologous bone marrow transplantation and peripheral blood stem cell transplantation after first remission induction treatment in multiple myeloma.

J. Bourhis, V. Leblond, G. Marit, 1995, Bone marrow transplantation.

HIGH DOSE MELPHALAN AND AUTOLOGOUS BONE MARROW TRANSPLANTATION IN HIGH RISK MYELOMA

J. Bourhis, J. Harousseau, N. Milpied, 1987, British journal of haematology.

Preliminary data of the GORTEC 2000-02 phase III trial comparing intravenous and subcutaneous administration of amifostine for head and neck tumors treated by external radiotherapy.

G. Calais, J. Bourhis, É. Bardet, 2002, Seminars in oncology.

PO-0888 Stereotactic body radiotherapy for refractory ventricular tachycardia: clinical outcomes

J. Bourhis, J. Schwitter, M. Zeverino, 2019, Radiotherapy and Oncology.

The prognostic impact of the cytomegalovirus serostatus in patients with chronic hematological malignancies after allogeneic hematopoietic stem cell transplantation: a report from the Infectious Diseases Working Party of EBMT

S. Montoto, J. Bourhis, N. Kröger, 2019, Annals of Hematology.

Unfractionated peripheral blood stem cell autografts and CD(34+)-enriched autografts have similar long-term culture initiating capacity in multiple myeloma.

J. Bourhis, W. Vainchenker, S. Novault, 1999, Hematology and cell therapy.

Engraftment of CD34+ peripheral blood progenitor cells into multiple myeloma patients following total body irradiation.

J. Bourhis, J. Pico, G. Tchernia, 1995, Nouvelle revue francaise d'hematologie.

Cost effectiveness of day 5 G-CSF (Lenograstim®) administration after PBSC transplantation: results of a SFGM-TC randomised trial

J. Bourhis, C. Gisselbrecht, A. Aupérin, 2005, Bone Marrow Transplantation.

Prognostic value of c-myc proto-oncogene overexpression in early invasive carcinoma of the cervix.

J. Bourhis, G. Riou, M. Barrois, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evaluation of infectious complications after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide following reduced-intensity and myeloablative conditioning: a study on behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-T

J. Bourhis, P. Chevallier, I. Yakoub-Agha, 2016, Bone Marrow Transplantation.

Flap Delineation Guidelines in Postoperative Head and Neck Radiation Therapy for head and neck cancers.

J. Bourhis, J. Thariat, P. Marcy, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A Personalized Approach to Guide Allogeneic Stem Cell Transplantation in Younger Adults with Acute Myeloid Leukemia.

J. Bourhis, H. Dombret, S. Chevret, 2020, Blood.

Added prognostic value of secondary AML-like gene mutations in ELN intermediate-risk older AML: ALFA-1200 study results.

J. Bourhis, H. Dombret, C. Preudhomme, 2020, Blood advances.

Randomized study of intensified anthracycline doses for induction and recombinant interleukin-2 for maintenance in patients with acute myeloid leukemia age 50 to 70 years: results of the ALFA-9801 study.

J. Bourhis, H. Dombret, S. Chevret, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial.

J. Bourhis, A. Hagemeijer, F. Mandelli, 2003, Blood.

Mechanisms of Disease: signaling of the insulin-like growth factor 1 receptor pathway—therapeutic perspectives in cancer

J. Bourhis, E. Deutsch, Y. Tao, 2007, Nature Clinical Practice Oncology.

Tyrphostin AG 1024 modulates radiosensitivity in human breast cancer cells

J. Bourhis, L. Maggiorella, E. Deutsch, 2001, British Journal of Cancer.

Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide versus Cyclosporine A and Methotrexate in Matched Sibling Donor Transplantation Transplantation and Cellular Therapy

J. Esteve, J. Bourhis, M. Labopin, 2022 .

Graft-Versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide versus Cyclosporine A and Methotrexate in Matched Sibling Donor Transplantation.

J. Esteve, J. Bourhis, M. Labopin, 2021, Transplantation and cellular therapy.

The impact of anti-thymocyte globulin on the outcomes of Patients with AML with or without measurable residual disease at the time of allogeneic hematopoietic cell transplantation

J. Esteve, J. Bourhis, M. Labopin, 2019, Leukemia.

Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.

Jacques Bernier, Michel Bolla, Mahmut Ozsahin, 2004, The New England journal of medicine.

Mixed treatment comparison meta-analysis of altered fractionated radiotherapy and chemotherapy in head and neck cancer.

J. Pignon, J. Bourhis, C. Guihenneuc‐Jouyaux, 2011, Journal of clinical epidemiology.

Adaptive radiotherapy for head and neck cancer

J Castelli, R de Crevoisier, C Lafond, 2018, Acta oncologica.

J. Bourhis, M. Robin, M. Rybojad, 2014, The British journal of dermatology.

FLASH radiotherapy International Workshop.

J. Bourhis, M. Baumann, R. Coppes, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

High-dose chemotherapy with etoposide, cyclophosphamide and escalating dose of carboplatin followed by autologous bone marrow transplantation in cancer patients. A pilot study.

J. Bourhis, P. Viens, D. Maraninchi, 1993, European journal of cancer.

Reply to Penack et al. and Wu

J. Bourhis, A. Aupérin, E. Chachaty, 2004 .

Enterocytozoon bieneusi Microsporidiosis in Stem Cell Transplant Recipients Treated with Fumagillin

J. Bourhis, B. Wyplosz, M. Thellier, 2017, Emerging infectious diseases.

[New elements in the diagnosis and the treatment of primary AL amyloid polyneuropathy and neuropathy due to POEMS syndrome].

J. Bourhis, C. Lacroix, P. Lozeron, 2011, Revue neurologique.

Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the French Society of Bone Marrow Transplantation and Ce

J. Bourhis, I. Yakoub-Agha, J. Golmard, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized study.

J. Bourhis, D. Blaise, M. Mohty, 2002, Blood.

Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Société Française de Greffe de Moelle.

J. Bourhis, D. Blaise, J. Moatti, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Should cytomegalovirus be tested for in both blood and bronchoalveolar lavage fluid of patients at a high risk of CMV pneumonia after bone marrow transplantation?

J. Bourhis, J. Bernaudin, A. Fajac, 1997, British journal of haematology.

Quantification of Human Cytomegalovirus DNA in Bone Marrow Transplant Recipients by Real-Time PCR

J. Bourhis, M. Barrois, D. Bellet, 2001, Journal of Clinical Microbiology.

Quantiﬁcation of Human Cytomegalovirus DNA in Bone Marrow Transplant Recipients by Real-Time PCR

J. Bourhis, M. Barrois, D. Bellet, 2001 .

Botulinum toxin for radiation-induced facial pain and trismus

J. Bourhis, M. Juliéron, P. Marandas, 2008, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data

J. Bourhis, Christian Domenge, JP Pignon, 2000, The Lancet.

Association between poor prognosis in early-stage invasive cervical carcinomas and non-detection of HPV DNA

J. Bourhis, G. Riou, G. Orth, 1990, The Lancet.

Salvage surgery after failure of very accelerated radiotherapy in advanced head-and-neck squamous cell carcinoma.

J. Bourhis, F. Janot, S. Temam, 2005, International journal of radiation oncology, biology, physics.

Full dose reirradiation combined with chemotherapy after salvage surgery in head and neck carcinoma

J. Bourhis, S. Koscielny, F. Eschwège, 2001, Cancer.

Assessment and management of cutaneous reactions with amifostine administration: findings of the ethyol (amifostine) cutaneous treatment advisory panel (ECTAP).

J. Bourhis, D. Brizel, M. Turner, 2004, International journal of radiation oncology, biology, physics.

Nasopharyngeal carcinomas: an update.

J. Pignon, J. Bourhis, J. Armand, 2003, European journal of cancer.

Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis.

Jun Ma, J. Pignon, J. Bourhis, 2015, The Lancet. Oncology.

Ultrahigh dose-rate FLASH irradiation increases the differential response between normal and tumor tissue in mice

Philippe Hupé, Janet Hall, Isabel Brito, 2014, Science Translational Medicine.

c-Myc regulates expression of NKG2D ligands ULBP1/2/3 in AML and modulates their susceptibility to NK-mediated lysis.

J. Bourhis, S. Chouaib, A. Mallavialle, 2014, Blood.

Novel Anti-Metastatic Action of Cidofovir Mediated by Inhibition of E6/E7, CXCR4 and Rho/ROCK Signaling in HPV+ Tumor Cells

P. Opolon, J. Bourhis, M. McKay, 2009, PloS one.

Subcutaneous compared with intravenous administration of amifostine in patients with head and neck cancer receiving radiotherapy: final results of the GORTEC2000-02 phase III randomized trial.

G. Calais, J. Bourhis, P. Garaud, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

JC human polyomavirus is associated to chromosomal instability in peripheral blood lymphocytes of Hodgkin's lymphoma patients and poor clinical outcome.

S. Flamant, J. Bourhis, S. Koscielny, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Enhancement of radiation response in p53-deficient cancer cells by the Aurora-B kinase inhibitor AZD1152

J. Bourhis, G. Kroemer, V. Frascogna, 2007, Oncogene.

Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma.

J. Bourhis, G. Wilson, G. Riou, 1991, Progress in clinical and biological research.

Down-regulation of BRCA1 in BCR-ABL-expressing hematopoietic cells.

Eric Deutsch, Jean Bourhis, J. Bourhis, 2003, Blood.

Surrogate End Points for Overall Survival in Loco-Regionally Advanced Nasopharyngeal Carcinoma

Federico Rotolo, Li Zhang, Stefan Michiels, 2017 .

Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients.

J. Pignon, J. Bourhis, S. Leung, 2006, International journal of radiation oncology, biology, physics.

Younger donor’s age and upfront tandem are two independent prognostic factors for survival in multiple myeloma patients treated by tandem autologous-allogeneic stem cell transplantation: a retrospective study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)

J. Bourhis, I. Yakoub-Agha, D. Blaise, 2012, Haematologica.

Cytogenetic assessment of heterogeneous radiation doses in cancer patients treated with fractionated radiotherapy.

J. Bourhis, A. Giraudet, P. Voisin, 2010, The British journal of radiology.

Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis

Brian O'Sullivan, Jacques Bernier, Richard Sylvester, 2006, The Lancet.

Debio 1143 and high-dose cisplatin chemoradiotherapy in high-risk locoregionally advanced squamous cell carcinoma of the head and neck: a double-blind, multicentre, randomised, phase 2 study.

N. Magné, B. Chauffert, J. Bourhis, 2020, The Lancet. Oncology.

Long‐term study of chimaerism in bone marrow transplantation recipients for severe aplastic anaemia

J. Bourhis, P. Lehn, E. Gluckman, 1989, British journal of haematology.

Effect of Ku80 depletion on the preintegrative steps of HIV-1 replication in human cells.

J. Bourhis, L. Jeanson, J. Mouscadet, 2002, Virology.

Clonal analysis of myelodysplastic syndrome: monosomy 7 is expressed in the myeloid lineage, but not in the lymphoid lineage as detected by fluorescent in situ hybridization.

S. Jhanwar, J. Bourhis, W. Gerritsen, 1992, Blood.

N-myc genomic content and DNA ploidy in stage IVS neuroblastoma.

J. Bourhis, C. Dominici, H. McDowell, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis.

B. Jeremic, M. Parmar, J. Pignon, 2021, The Lancet. Oncology.

Burkitt's acute lymphocytic leukemia (L3ALL) in adults.

J. Bourhis, P. Fenaux, V. Ribrag, 2001, Hematology/oncology clinics of North America.

Update of MACH-NC (Meta-Analysis of Chemotherapy in Head & Neck Cancer) database focused on concomitant chemoradiotherapy

J. Pignon, J. Bourhis, C. Amand, 2004 .

Update of MACH-NC (Meta-Analysis of Chemotherapy in Head & Neck Cancer) database focused on concomitant chemoradiotherapy.

J. Pignon, J. Bourhis, C. Amand, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia.

J. Bourhis, H. Dombret, P. Chevallier, 2015, Blood.

Nanoscale radiotherapy with hafnium oxide nanoparticles.

Gilles Barouch, Eric Deutsch, Laurent Levy, 2012, Future oncology.

Expression of a human multidrug resistance gene in ovarian carcinomas.

I. Pastan, M. Gottesman, J. Bourhis, 1989, Cancer research.

Molecular profiling of uterine cervix carcinoma: an overview with a special focus on rationally designed target-based anticancer agents

C. Haie-meder, N. Magné, Cyrus Chargari, 2008, Cancer and Metastasis Reviews.

Cyclooxygenase-2 inhibitor NS398 enhances antitumor effect of irradiation on hormone refractory human prostate carcinoma cells.

J. Bourhis, F. Eschwège, R. de Crevoisier, 2003, The Journal of urology.

Stem cell transplantation from a haploidentical donor versus a genoidentical sister for adult male patients with acute myelogenous leukemia in first remission: A retrospective study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation

J. Bourhis, M. Labopin, D. Blaise, 2019, Cancer.

Allogeneic stem cell transplantation in acute lymphoblastic leukemia and non-Hodgkin’s lymphoma for patients ≤£ 50 years old in first complete remission: results of the EORTC ALL-3 trial

J. Bourhis, R. Willemze, R. Zittoun, 2004 .

Chromosome 11q13 gene amplifications in oral and oropharyngeal carcinomas: no correlation with subclinical lymph node invasion and disease recurrence.

J. Bourhis, A. Fortin, J. Bosq, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

Correlation of MDR1 gene expression with chemotherapy in neuroblastoma.

J. Bourhis, G. Riou, O. Hartmann, 1989, Journal of the National Cancer Institute.

Selection of lymph node target volumes for definitive head and neck radiation therapy: a 2019 Update.

J. Kazmierska, V. Grégoire, J. Bourhis, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Current concepts of management in radiotherapy for head and neck squamous-cell cancer.

J. Bourhis, Y. Tao, A. Lusinchi, 2009, Oral oncology.

Oral cavity squamous cell carcinoma in 260 patients aged 80years or more.

R. Arriagada, J. Bourhis, A. Italiano, 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Radiotherapy in head and neck cancer in the elderly: a challenge.

J. Bourhis, F. Eschwège, R. de Crevoisier, 2000, Critical reviews in oncology/hematology.

Autologous and allogeneic stem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans-retinoic acid: a retrospective analysis of the European acute promyelocytic leukemia group.

J. Bourhis, H. Dombret, S. Chevret, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[Angiogenesis: all a radiation oncologist should know].

J. Bourhis, R. Mazeron, E. Deutsch, 2008, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Dependence on Phosphoinositide 3-Kinase and RAS-RAF Pathways Drive the Activity of RAF265, a Novel RAF/VEGFR2 Inhibitor, and RAD001 (Everolimus) in Combination

J. Bourhis, J. Calderaro, J. Soria, 2010, Molecular Cancer Therapeutics.

Efficacy and safety of helical tomotherapy with daily image guidance in anal canal cancer patients

R. Mirimanoff, J. Bourhis, B. De Bari, 2016, Acta oncologica.

Adjusting for patient selection suggests the addition of docetaxel to 5-fluorouracil–cisplatin induction therapy may offer survival benefit in squamous cell cancer of the head and neck

M. Mazumdar, J. Pignon, J. Bourhis, 2004, Anti-cancer drugs.

Split-course hypofractionated radiotherapy for aged and frail patients with head and neck cancers. A retrospective study of 75 cases.

J. Bourhis, R. Sun, E. Gherga, 2020, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Autologous peripheral-blood progenitor-cell support following high-dosechemotherapy or chemoradiotherapy in patients with high-risk multiple myeloma.

J. Bourhis, P. Cony-Makhoul, J. Reiffers, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation

J. Bourhis, D. Blaise, M. Mohty, 2003, Leukemia.

SECOND ALLOGENEIC STEM CELL TRANSPLANTATION: A MORTALITY ANALYSIS

J. Bourhis, M. Alani, 2020, medRxiv.

Hypofractionated radiotherapy in pancreatic cancer: Lessons from the past in the era of stereotactic body radiation therapy.

M. Schäfer, J. Bourhis, F. Alongi, 2016, Critical reviews in oncology/hematology.

Influence of alternative donor type on early survival after hematopoietic stem cell transplantation for acute myeloid leukemia lacking a sibling donor

J. Bourhis, P. Chevallier, I. Yakoub-Agha, 2019, Bone Marrow Transplantation.

Comparison of unrelated cord blood and peripheral blood stem cell transplantation in adults with myelodysplastic syndrome after reduced-intensity conditioning regimen: a collaborative study from Eurocord (Cord blood Committee of Cellular Therapy & Immunobiology Working Party of EBMT) and Chronic Mal

J. Bourhis, C. Craddock, M. Labopin, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Double Cord Blood Transplantation: Incidence, Organ Involvement and Risk Factors of Acute Graft Versus Host Disease. a Retrospective Analysis on Behalf of Eurocord, ALWP and Cqwp-EBMT

J. Bourhis, C. Craddock, M. Labopin, 2014 .

Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

J. Bourhis, M. Labopin, A. Nagler, 2021, Journal of Hematology & Oncology.

Serum interleukin-12 levels in patients undergoing allogeneic or autologous bone marrow transplantation.

J. Blay, J. Bourhis, B. Bonnotte, 1996, European cytokine network.

Lenalidomide as salvage treatment for multiple myeloma relapsing after allogeneic hematopoietic stem cell transplantation: a report from the French Society of Bone Marrow and Cellular Therapy

J. Bourhis, I. Yakoub-Agha, M. Mohty, 2013, Haematologica.

Prospective comparison of autologous stem cell transplantation followed by dose-reduced allograft (IFM99-03 trial) with tandem autologous stem cell transplantation (IFM99-04 trial) in high-risk de novo multiple myeloma.

J. Bourhis, I. Yakoub-Agha, P. Moreau, 2006, Blood.

Impact of antithymocyte globulin doses in reduced intensity conditioning before allogeneic transplantation from matched sibling donor for patients with acute myeloid leukemia: a report from the acute leukemia working party of European group of Bone Marrow Transplantation

J. Bourhis, G. Mufti, F. Baron, 2018, Bone Marrow Transplantation.

Impact of antithymocyte globulin on outcomes of allogeneic hematopoietic cell transplantation with TBI.

J. Bourhis, M. Labopin, A. Nagler, 2019, Blood advances.

Higher Doses of Antithymocyte Globulin (ATG) Increase the Risk of Relapse in Acute Myeloid Leukemia (AML) Patients Undergoing Matched Related Donor Allogeneic Transplantation in First Complete Remission (CR1): An Analysis from the Acute Leukemia Working Party of EBMT

J. Bourhis, F. Baron, M. Labopin, 2014 .

Combined G-CSF and Plerixafor enhance hematopoietic recovery of CD34+ cells from poor mobilizer patients in NSG mice.

J. Bourhis, M. Arcangeli, S. Koscielny, 2020, Experimental hematology.

Relapse from a stage IV-S neuroblastoma and N-myc amplification.

J. Bourhis, G. Riou, O. Hartmann, 1989, European journal of cancer & clinical oncology.

Highly sensitive polymerase chain reaction methods show the frequent survival of residual recipient multipotent progenitors after non−T-cell−depleted bone marrow transplantation

J. Bourhis, G. Socié, E. Gluckman, 1994 .

Highly sensitive polymerase chain reaction methods show the frequent survival of residual recipient multipotent progenitors after non-T-cell-depleted bone marrow transplantation.

J. Bourhis, G. Socié, E. Gluckman, 1994, Blood.

Scoring system for clinically significant CMV infection in seropositive recipients following allogenic hematopoietic cell transplant: an SFGM-TC study

J. Bourhis, P. Chevallier, I. Yakoub-Agha, 2020, Bone Marrow Transplantation.

Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Société Française de Greffe de Moelle et de Thérapie Cellulaire.

J. Bourhis, I. Yakoub-Agha, D. Blaise, 2008, Experimental hematology.

Leukemic target susceptibility to natural killer cytotoxicity: relationship with BCR-ABL expression.

J. Bourhis, F. Baron, V. Bours, 2002, Blood.

Detection of recipient cells after non T-cell depleted bone marrow transplantation for leukemia by PCR amplification of minisatellites or of a Y chromosome marker has a different prognostic value.

J. Bourhis, G. Socié, B. Raynal, 1994, Leukemia.

Cost and efficacy of peripheral stem cell mobilization strategies in multiple myeloma

J. Bourhis, P. Moreau, M. Macro, 2020, Bone Marrow Transplantation.

Role of cancer treatment in long-term overall and cardiovascular mortality after childhood cancer.

J. Bourhis, D. Lefkopoulos, F. de Vathaire, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

miR-181a modulates acute myeloid leukemia susceptibility to natural killer cells

J. Bourhis, D. Olive, P. Dessen, 2015, Oncoimmunology.

Implementation of TomoEDGE in the independent dose calculator CheckTomo

J. Bourhis, F. Bochud, R. Moeckli, 2017, Journal of applied clinical medical physics.

Protein-losing gastropathy associated with cytomegalovirus: a rare and late complication of allogeneic bone marrow transplantation.

J. Bourhis, J. Pico, C. Buffet, 1996, Bone marrow transplantation.

[Pharmacological targeting of Mdm2: rationale and perspectives for radiosensitization].

Cyrus Chargari, J. Bourhis, C. Ferté, 2011, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Telomere shortening and associated chromosomal instability in peripheral blood lymphocytes of patients with Hodgkin's lymphoma prior to any treatment are predictive of second cancers.

J. Bourhis, S. Koscielny, A. Bernheim, 2007, International journal of radiation oncology, biology, physics.

Cidofovir Administered with Radiation Displays an Antiangiogenic Effect Mediated by E6 Inhibition and Subsequent TP53-Dependent VEGF Repression in HPV18+ Cell Lines

J. Bourhis, M. Vozenin-Brotons, C. Aubel, 2006, Radiation research.

Caspase independence of radio-induced cell death

J. Bourhis, G. Kroemer, P. Zhang, 2006, Oncogene.

Multifaceted Role of the Transforming Growth Factor β on Effector T Cells and the Implication for CAR-T Cell Therapy

J. Bourhis, S. Terry, S. Chouaib, 2021, Immuno.

Pravastatin Reverses Established Radiation-Induced Cutaneous and Subcutaneous Fibrosis in Patients With Head and Neck Cancer: Results of the Biology-Driven Phase 2 Clinical Trial Pravacur.

J. Bourhis, P. Taourel, N. Lassau, 2019, International journal of radiation oncology, biology, physics.

Influence of Nucleoshuttling of the ATM Protein in the Healthy Tissues Response to Radiation Therapy: Toward a Molecular Classification of Human Radiosensitivity.

J. Bourhis, D. Stoppa-Lyonnet, A. Puisieux, 2016, International journal of radiation oncology, biology, physics.

Radiosensitization by Chir-124, a selective Chk1 inhibitor: Effects of p53 and cell cycle checkpoints

J. Bourhis, G. Kroemer, R. Golsteyn, 2009, Cell cycle.

Angiogenesis and tumor growth inhibition by a matrix metalloproteinase inhibitor targeting radiation-induced invasion

P. Opolon, J. Bourhis, K. Cengel, 2005, Molecular Cancer Therapeutics.

Prospective randomized comparison of single-dose versus hyperfractionated total-body irradiation in patients with hematologic malignancies.

J. Bourhis, J. Cosset, G. Socié, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cellular Composition and Contribution of Tertiary Lymphoid Structures to Tumor Immune Infiltration and Modulation by Radiation Therapy

J. Bourhis, E. Meylan, S. Rusakiewicz, 2018, Front. Oncol..

Coronary stenosis risk analysis following Hodgkin lymphoma radiotherapy: A study based on patient specific artery segments dose calculation.

J. Bourhis, D. Lefkopoulos, D. Drubay, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Outcome of acute promyelocytic leukemia treated with all trans retinoic acid and chemotherapy in elderly patients: the European group experience

J. Miguel, J. Bourhis, H. Dombret, 2005, Leukemia.

Impact of the type of anthracycline and of stem cell transplantation in younger patients with acute myeloid leukaemia: Long‐term follow up of a phase III study

J. Bourhis, M. Vignetti, P. Chiusolo, 2020, American journal of hematology.

modulates their susceptibility to NK-mediated lysis c-Myc regulates expression of NKG 2 D ligands ULBP 1 / 2 / 3 in AML and

J. Bourhis, S. Chouaib, A. Mallavialle, 2014 .

Meta-analyses in head and neck squamous cell carcinoma. What is the role of chemotherapy?

J. Pignon, J. Bourhis, J. Bourhis, 1999, Hematology/oncology clinics of North America.

Multiple molecular mechanisms contribute to radiation sensitivity in mantle cell lymphoma

J. Bourhis, D. Stoppa-Lyonnet, A. Bernheim, 2003, Oncogene.

High‐dose therapy and autologous stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL‐GITMO

S. Montoto, J. Bourhis, P. Dreger, 2018, British journal of haematology.

Severe acute respiratory syndrome coronavirus 2 vaccination for patients with solid cancer: Review and point of view of a French oncology intergroup (GCO, TNCD, UNICANCER)

J. Blay, K. Hoang-Xuan, J. Bourhis, 2021, European Journal of Cancer.

Prognostic Relevance of pS2 Status With Steroid Receptor Status and in Association Proliferative Activity in Node-negative Breast Cancer

J. Bourhis, F. Guilhot, N. Milpied, 1992 .

Phase III study of tirapazamine, cisplatin and radiation versus cisplatin and radiation for advanced squamous cell carcinoma of the head and neck

R. Fisher, J. Bourhis, B. O'Sullivan, 2008 .

[Late effects of radiations on mature and growing bone].

J. Bourhis, F. Mornex, O. Ramuz, 1997, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Human papillomavirus-negative status and c-myc gene overexpression: independent prognostic indicators of distant metastasis for early-stage invasive cervical cancers.

J. Bourhis, G. Riou, M. Lê, 1992, Journal of the National Cancer Institute.

J. Bourhis, S. Koscielny, A. Bernheim, 2003, British journal of haematology.

Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey

S. Montoto, J. Bourhis, N. Kröger, 2020, Bone Marrow Transplantation.

[Cutaneous localization of multiple myeloma on the tract of a central venous catheter].

J. Bourhis, J. Bosq, M. Avril, 2002, Annales de dermatologie et de venereologie.

Impact of disease status and stem cell source on the results of reduced intensity conditioning transplant for Hodgkin’s lymphoma: a retrospective study from the French Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)

R. Porcher, J. Bourhis, M. Bernard, 2013, Haematologica.

Hypoxia in Head and Neck Cancers: Clinical Relevance and Treatment

J. Bourhis, Y. Tao, 2011 .

transplantation: long-term results of a randomized study Chronic graft-versus-host disease after allogeneic blood stem cell

J. Bourhis, D. Blaise, M. Mohty, 2013 .

Commissioning of an ultra-high dose rate pulsed electron beam medical LINAC for FLASH RT pre-clinical animal experiments and future clinical human protocols.

J. Bourhis, N. Cherbuin, F. Bochud, 2021, Medical physics.

Long-term neurocognitive benefits of FLASH radiotherapy driven by reduced reactive oxygen species

J. Bourhis, F. Bochud, R. Moeckli, 2019, Proceedings of the National Academy of Sciences.

Reply to N.F. Saba and S.J. Wong.

J. Bourhis, K. Harrington, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I study of lapatinib in combination with chemoradiation in patients with locally advanced squamous cell carcinoma of the head and neck.

J. Bourhis, K. Harrington, C. Nutting, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

End points for new agents in induction chemotherapy for locally advanced head and neck cancers.

J. Bourhis, E. Raymond, C. Monnerat, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Analysis of p53 serum antibodies in patients with head and neck squamous cell carcinoma.

J. Bourhis, S. Koscielny, T. Soussi, 1996, Journal of the National Cancer Institute.

J. Bourhis, P. Chevallier, I. Yakoub-Agha, 2018, American journal of hematology.

Outcome of patients with distinct molecular genotypes and cytogenetically normal AML after allogeneic transplantation.

J. Esteve, J. Bourhis, F. Baron, 2015, Blood.

Germline ATG2B/GSKIP-containing 14q32 duplication predisposes to early clonal hematopoiesis leading to myeloid neoplasms

F. Pasquier, J. Bourhis, C. Deswarte, 2021, Leukemia.

Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia--results of the prospective multicenter LALA-94 trial.

J. Bourhis, J. Cayuela, H. Dombret, 2002, Blood.

50-Gy Stereotactic Body Radiation Therapy to the Dominant Intraprostatic Nodule: Results From a Phase 1a/b Trial.

Patrice Jichlinski, George Coukos, Berardino De Bari, 2019, International journal of radiation oncology, biology, physics.

Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.

J. Bourhis, C. Keever, N. Collins, 1989, Journal of immunology.

X-rays can trigger the FLASH effect: Ultra-high dose-rate synchrotron light source prevents normal brain injury after whole brain irradiation in mice.

J. Bourhis, M. Jaccard, D. Patin, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Evaluation of a disease risk index for adult patients undergoing umbilical cord blood transplantation for haematological malignancies

J. Bourhis, N. Ifrah, E. Gluckman, 2017, British journal of haematology.

Autologous stem cell transplantation after first remission induction treatment in multiple myeloma: A report of the french registry on autologous transplantation in multiple myeloma

R. Bataille, J. Bourhis, X. Troussard, 1995, Blood.

Effect of immune modulation in relapsed peripheral T-cell lymphomas after post-allogeneic stem cell transplantation: a study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)

J. Bourhis, P. Chevallier, D. Blaise, 2016, Bone Marrow Transplantation.

Isocitrate Dehydrogenase (IDH) 1 and 2 Mutation Is an Independent Predictor of Better Outcome in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Study of the ALWP of EBMT

J. Esteve, A. Ganser, J. Bourhis, 2021, Blood.

Combining immunotherapy and radiotherapy in head and neck squamous cell cancers: which perspectives?

J. Bourhis, J. Biau, 2020, Current opinion in oncology.

Postremission treatment of elderly patients with acute myeloid leukemia in first complete remission after intensive induction chemotherapy: results of the multicenter randomized Acute Leukemia French Association (ALFA) 9803 trial.

J. Bourhis, H. Dombret, C. Preudhomme, 2007, Blood.

Effect of Priming with Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Younger Adults with Newly Diagnosed Acute Myeloid Leukemia (AML): A Trial by the Acute Leukemia French Association (ALFA) Group.

J. Bourhis, H. Dombret, B. Quesnel, 2005 .

Outcomes after allogeneic hematopoietic cell transplant in patients diagnosed with blast phase of myeloproliferative neoplasms: A retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation

J. Bourhis, M. Robin, I. Yakoub-Agha, 2023, American journal of hematology.

Real-world use of defibrotide for veno-occlusive disease/sinusoidal obstruction syndrome: the DEFIFrance Registry Study

J. Bourhis, M. Labopin, I. Yakoub-Agha, 2022, Bone Marrow Transplantation.

Allogeneic hematopoietic cell transplantation in acute myeloid leukemia with normal karyotype and isolated Nucleophosmin-1 (NPM1) mutation: outcome strongly correlates with disease status

J. Esteve, J. Bourhis, M. Labopin, 2016, Haematologica.

Prognostic significance of recurring chromosomal abnormalities in transplanted patients with acute myeloid leukemia

J. Esteve, J. Bourhis, M. Labopin, 2019, Leukemia.

Fludarabine or cyclophosphamide in combination with total body irradiation as myeloablative conditioning prior to allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia: an analysis by the Acute Leukemia Working Party of the EBMT

J. Bourhis, M. Labopin, A. Nagler, 2023, Bone Marrow Transplantation.

Autologous versus allogeneic hematopoietic cell transplantation for older patients with acute lymphoblastic leukemia. An analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

J. Bourhis, M. Labopin, I. Yakoub-Agha, 2023, Bone Marrow Transplantation.

Reduced 8-Gray Compared to Standard 12-Gray Total Body Irradiation for Allogeneic Transplantation in First Remission Acute Lymphoblastic Leukemia: A Study of the Acute Leukemia Working Party of the EBMT

A. Ganser, J. Bourhis, M. Labopin, 2023, HemaSphere.

Allogeneic stem cell transplantation in second complete remission for core binding factor acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

J. Esteve, J. Bourhis, G. Mufti, 2019, Haematologica.

Prevention of Menstruation with Leuprorelin (GnRH Agonist) in Women Undergoing Myelosuppressive Chemotherapy or Radiochemotherapy for Hematological Malignancies: a Pilot Study

J. Bourhis, P. Dietrich, J. Pico, 2001, Leukemia & lymphoma.

Retrospective Study of Allogeneic Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome-Positive Leukemia: 25 Years' Experience at Gustave Roussy Cancer Campus.

J. Bourhis, S. de Botton, C. Willekens, 2015, Clinical lymphoma, myeloma & leukemia.

Comparative outcomes of myeloablative and reduced‐intensity conditioning allogeneic hematopoietic cell transplantation for therapy‐related acute myeloid leukemia with prior solid tumor: A report from the acute leukemia working party of the European society for blood and bone marrow transplantation

A. Ganser, J. Bourhis, M. Labopin, 2019, American journal of hematology.

Clinical efficacy of second generation tyrosine kinase inhibitor and 5-azacytidine combination in chronic myelogenous leukaemia in myeloid blast crisis.

F. Pasquier, J. Bourhis, S. de Botton, 2013, European journal of cancer.

Shannon R. McCurdy, J. Bourhis, M. Labopin, 2018, Blood advances.

Distinct factors determine the kinetics of disease relapse in adults transplanted for acute myeloid leukaemia

P. Vyas, J. Bourhis, C. Craddock, 2018, Journal of internal medicine.

Prospective randomized comparison of single-dose versus hyperfractionated total-body irradiation in patients with hematologic malignancies

J. Bourhis, J. Cosset, G. Socié, 2001 .

A haploidentical may be a better choice than a female genoidentical donor to transplant a patient with high risk acute myelogenous leukemia in first remission

J. Bourhis, M. Labopin, D. Blaise, 2019 .

Acute myeloid leukemia Prognostic signi fi cance of recurring chromosomal abnormalities in transplanted patients with acute myeloid leukemia

J. Esteve, J. Bourhis, M. Labopin, 2019 .

Maintenance Treatment with Thalidomide after Autologous Transplantation for Myeloma : First Analysis of a Prospective Randomized Study of the Intergroupe Francophone du Myelome (IFM 99 02).

B. Coiffier, J. Bourhis, S. Leyvraz, 2004 .

First line chemotherapy for patients with multiple myeloma with vad regimen followed by consolidation with high-dose chemoradiotherapy with peripheral stem cells autograft (PSCA): the experience of IGR center

J. Bourhis, J. Pico, M. Hayat, 1994 .

Retrospective Comparison between 12-Gray and 8-Gray Total Body Irradiation (TBI) before Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Lymphoblastic Leukemia in First Complete Remission

A. Ganser, J. Bourhis, N. Kröger, 2021, Blood.

[Transfer of allogeneic stem cell transplant recipients to the intensive care unit: Guidelines from the Francophone society of marrow transplantation and cellular therapy (SFGM-TC)].

J. Bourhis, I. Yakoub-Agha, A. Moreau, 2016, Bulletin du cancer.

Medication non‐adherence after allogeneic hematopoietic cell transplantation in adult and pediatric recipients: a cross sectional study conducted by the Francophone Society of Bone Marrow Transplantation and Cellular Therapy

J. Bourhis, I. Yakoub-Agha, J. Bay, 2020, Fundamental & clinical pharmacology.

[Usefulness of panfungal PCR for the diagnosis of fungal infection in immunocompromised patients].

J. Bourhis, O. Casiraghi, M. Merad, 2004, Pathologie-biologie.

[Hopes of high dose-rate radiotherapy].

J. Bourhis, M. Dutreix, P. Romeo, 2017, Bulletin du cancer.

How could breast cancer molecular features contribute to locoregional treatment decision making?

J. Bourhis, P. Tsoutsou, M. Vozenin, 2017, Critical reviews in oncology/hematology.

Modern intensity-modulated radiotherapy with image guidance allows low toxicity rates and good local control in chemoradiotherapy for anal cancer patients

J. Bourhis, R. Miralbell, M. Ozsahin, 2018, Journal of Cancer Research and Clinical Oncology.

Comparison of dose contribution to normal pelvic tissues among conventional, conformal and intensity-modulated radiotherapy techniques in prostate cancer

R. Arriagada, J. Bourhis, D. Lefkopoulos, 2008, Acta oncologica.

Meta-Analyses of Chemotherapy in Head and Neck Cancer (MACH-NC): an update.

J. Pignon, J. Bourhis, A. le Maître, 2007, International journal of radiation oncology, biology, physics.

Randomised trial of re-irradiation combined with chemotherapy after salvage surgery in head and neck carcinoma: Carcinologic and quality of life results GETTEC and GORTEC groups

J. Bourhis, E. Babin, M. Hamoir, 2007 .

Re-irradiation combined with chemotherapy after salvage surgery in head and neck carcinoma: A randomized trial from the GETTEC and GORTEC groups.

J. Bourhis, M. Hamoir, F. Janot, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data.

Tomasz Burzykowski, Marc Buyse, Stefan Michiels, 2009, The Lancet. Oncology.

LBA38 Pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Results of the GORTEC 2015-01 “PembroRad” randomized trial

J. Bourhis, J. Prevost, C. Sire, 2020, Annals of Oncology.

[Larynx preservation: nonsurgical approaches].

J. Bourhis, F. Janot, S. Temam, 2004, Cancer Radiothérapie.

Decreased DNA-PK activity in human cancer cells exhibiting hypersensitivity to low-dose irradiation

P. Lambin, J. Bourhis, F. Eschwège, 2000, British Journal of Cancer.

Irradiation in a flash: Unique sparing of memory in mice after whole brain irradiation with dose rates above 100Gy/s.

Claude Bailat, Kristoffer Petersson, François Bochud, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

SP-010: Update of the meta-analysis of chemotherapy in head and neck cancer (MACH-NC)

J. Pignon, J. Bourhis, P. Blanchard, 2017 .

New techniques in radiation therapy for head and neck cancer: IMRT, CyberKnife, protons, and carbon ions. Improved effectiveness and safety? Impact on survival?

Pascal Pommier, Jean Bourhis, Juliette Thariat, 2011, Anti-cancer drugs.

Radiation therapy for head and neck cancers in the elderly.

J. Bourhis, F. Eschwège, A. Lusinchi, 1990, International journal of radiation oncology, biology, physics.

[Quality criteria in radiotherapy for head and neck cancers under the aegis of Head and Neck Intergroup].

M. Tomsej, J. Bourhis, Y. Tao, 2014, Bulletin du cancer.

[Oropharyngeal cancer].

G. Calais, J. Bourhis, C. Lafond, 2010, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Improved Outcome by Adding Concurrent Chemotherapy to Cetuximab and Radiotherapy for Locally Advanced Head and Neck Carcinomas: Results of the GORTEC 2007-01 Phase III Randomized Trial.

J. Bourhis, C. Borel, P. Maingon, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Implications of learning effects for hospital costs of new health technologies: The case of intensity modulated radiation therapy

G. de Pouvourville, J. Bourhis, D. Lefkopoulos, 2007, International Journal of Technology Assessment in Health Care.

Chromosomal Minimal Critical Regions in Therapy-Related Leukemia Appear Different from Those of De Novo Leukemia by High-Resolution aCGH

J. Bourhis, P. Dessen, C. Richon, 2011, PloS one.

Neoadjuvant chemoradiotherapy delivered with helical tomotherapy under daily image guidance for rectal cancer patients: efficacy and safety in a large, multi-institutional series

J. Bourhis, M. Zeverino, M. Montemurro, 2019, Journal of Cancer Research and Clinical Oncology.

A new method of assessing the dose-carcinogenic effect relationship in patients exposed to ionizing radiation. A concise presentation of preliminary data.

J. Bourhis, D. Lefkopoulos, M. Tubiana, 2011, Health physics.

Individual patient-versus literature-based meta-analysis of survival data: time to event and event rate at a particular time can make a difference, an example based on head and neck cancer.

J. Pignon, J. Bourhis, R. Sylvester, 2001, Controlled clinical trials.

Helical Tomotherapy for the Treatment of Anal Canal Cancer: A Dosimetric Comparison with 3D Conformal Radiotherapy

J. Bourhis, R. Moeckli, M. Ozsahin, 2015, Tumori.

Impact of age on treatment effect in locally advanced head and neck cancer (HNC): Two individual patient data meta-analyses.

J. Bourhis, M. Saunders, J. Bernier, 2006, Journal of Clinical Oncology.

Surrogate End Points for Overall Survival in Loco-Regionally Advanced Nasopharyngeal Carcinoma: An Individual Patient Data Meta-analysis

Federico Rotolo, Stefan Michiels, George Fountzilas, 2017, Journal of the National Cancer Institute.

The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis.

J C Horiot, A. Hart, H. Bartelink, 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Potential doubling time and clinical outcome in head and neck squamous cell carcinoma treated with 70 GY in 7 weeks.

J. Bourhis, A. Fortin, G. Wilson, 1996, International journal of radiation oncology, biology, physics.

Metabolic Tumor Volume and Total Lesion Glycolysis in Oropharyngeal Cancer Treated With Definitive Radiotherapy: Which Threshold Is the Best Predictor of Local Control?

Adrien Depeursinge, Renaud de Crevoisier, Joël Castelli, 2017, Clinical nuclear medicine.

A PET-based nomogram for oropharyngeal cancers.

J Castelli, A Depeursinge, John O. Prior, 2017, European journal of cancer.

UPDATE OF META-ANALYSES AND EBM LEVEL 1 ON: CONCOMI- TANT AND INDUCTION CHEMOTHERAPY

J. Bourhis, P. Blanchard, 2011 .

Altered fractionated radiotherapy in head and neck cancer – Authors' reply

J. Pignon, J. Bourhis, A. L. Maître, 2006, The Lancet.

Dose escalation of radiotherapy (RT) for locally advanced head and neck carcinomas treated with concomitant chemotherapy (CT) and RT: Results of the GORTEC 2004-01 randomized trial.

J. Bourhis, J. Thariat, A. Aupérin, 2017 .

Tyrosine kinase inhibitor AG1024 exerts antileukaemic effects on STI571-resistant Bcr-Abl expressing cells and decreases AKT phosphorylation

J. Bourhis, L. Maggiorella, V. Frascogna, 2004, British Journal of Cancer.

In air and in vivo measurement of the leaf open time in tomotherapy using the on-board detector pulse-by-pulse data.

François O Bochud, Jean Bourhis, Raphaël Moeckli, 2019, Medical physics.

Molecular markers predicting radiotherapy response: report and recommendations from an International Atomic Energy Agency technical meeting.

Michael Baumann, Karin Haustermans, Jolyon H Hendry, 2005, International journal of radiation oncology, biology, physics.

Dosimetric and preparation procedures for irradiating biological models with pulsed electron beam at ultra-high dose-rate.

J. Bourhis, F. Bochud, M. Jaccard, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

High dose‐per‐pulse electron beam dosimetry: Usability and dose‐rate independence of EBT3 Gafchromic films

J. Bourhis, F. Bochud, M. Jaccard, 2017, Medical physics.

Hyperfractionated and/or accelerated radiotherapy versus conventional radiotherapy for head and neck cancer

J. Pignon, J. Bourhis, R. Sylvester, 2000 .

Impact of p16 expression on induction taxotere-cisplatin-5 FU (TPF) followed by cetuximab-radiotherapy in N2b-N3 head and neck squamous cell carcinoma (HNSCC): Results of GORTEC 2007-02 phase III randomized trial.

J. Bourhis, E. Babin, P. Maingon, 2017 .

Evidence of BCR-ABL1-positive progenitor spread in blood during molecular recurrence after TKI discontinuation in chronic myeloid leukemia (CML)

J. Bourhis, A. Bennaceur-Griscelli, C. Desterke, 2020, Leukemia & lymphoma.

Evidence of massive leukemic progenitor expansion in blood during molecular recurrence after TKI discontinuation in chronic myeloid leukemia (CML)

J. Bourhis, A. Bennaceur-Griscelli, C. Desterke, 2019, bioRxiv.

Combined radiation sensitizing and anti-angiogenic effects of ionizing radiation and the protease inhibitor ritonavir in a head and neck carcinoma model.

P. Opolon, J. Bourhis, L. Maggiorella, 2005, Anticancer research.

Inhibiting bcl-2 in small cell lung cancer cell lines with oblimersen, an antisense bcl-2 oligodeoxynucleotides (ODN) is an effective strategy to enhance the efficacy of radiation in vitro and in vivo

J. Bourhis, J. Soria, Y. Loriot, 2007 .

Differential effect triggered by a heparan mimetic of the RGTA family preventing oral mucositis without tumor protection.

P. Opolon, J. Bourhis, V. Frascogna, 2009, International journal of radiation oncology, biology, physics.

Long term impact of hyperleukocytosis in newly diagnosed acute myeloid leukemia patients undergoing allogeneic stem cell transplantation: An analysis from the acute leukemia working party of the EBMT

J. Bourhis, M. Labopin, P. Chevallier, 2017, American journal of hematology.

Long term impact of hyperleukocytosis in newly diagnosed acute myeloid leukemia patients undergoing allogeneic stem cell transplantation

J. Bourhis, M. Labopin, P. Chevallier, 2022 .

Comparison of Dynamic International Prognostic Scoring System and MYelofibrosis SECondary to PV and ET Prognostic Model for Prediction of Outcome in Polycythemia Vera and Essential Thrombocythemia Myelofibrosis after Allogeneic Stem Cell Transplantation.

J. Bourhis, R. Fanin, N. Kröger, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Phase I/II study of cetuximab in combination with cisplatin or carboplatin and fluorouracil in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.

J. Bourhis, C. Borel, A. Schueler, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Abscopal effect in a patient with malignant pleural mesothelioma treated with palliative radiotherapy and pembrolizumab

G. Coukos, J. Bourhis, S. Peters, 2021, Clinical and translational radiation oncology.

BMS-690514, a VEGFR and EGFR tyrosine kinase inhibitor, shows anti-tumoural activity on non-small-cell lung cancer xenografts and induces sequence-dependent synergistic effect with radiation

J. Bourhis, P. Mordant, Y. Loriot, 2010, British Journal of Cancer.

Novel inverse planning optimization algorithm for robotic radiosurgery: First clinical implementation and dosimetric evaluation.

J. Bourhis, F. Bochud, M. Zeverino, 2019, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

P3 The impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients. Matched-pair comparison with conventional radiotherapy

J. Bourhis, P. Giraud, P. Maingon, 2007 .

Successful pregnancy after allogeneic bone marrow transplantation following conditioning including a 10-Gy single exposure total body irradiation.

J. Bourhis, P. Moreau, P. Sagot, 1996, Bone marrow transplantation.

In vivo measurement of the potential doubling time by flowcytometry in oropharyngeal cancer treated by conventional radiotherapy.

J. Bourhis, G. Wilson, J. Bosq, 1993, International journal of radiation oncology, biology, physics.

Status of accelerated fractionation radiotherapy in head and neck squamous cell carcinomas.

J. Bourhis, F. Eschwège, S. Bobin, 1997, Current opinion in oncology.

Outcomes of graft failure after umbilical cord blood transplantation in acute leukemia: a study from Eurocord and the Acute Leukemia Working Party of the EBMT

J. Bourhis, F. Baron, M. Labopin, 2023, Bone Marrow Transplantation.

OC-0039: Unique sparing of spatial memory in mice after whole brain irradiation with dose rates above 100Gy/s

J. Bourhis, F. Bochud, M. Jaccard, 2017 .

What is the most effective treatment for head and neck squamous cell carcinoma? An individual patient data network meta-analysis from the MACH-NC and MARCH collaborative groups

M. Parmar, J. Pignon, V. Grégoire, 2017 .

Impact of respiratory-correlated CT sorting algorithms on the choice of margin definition for free-breathing lung radiotherapy treatments.

François Bochud, Raphaël Moeckli, Jean Bourhis, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Locally advanced head and neck cancer: meta-analysis of updated individual data

J. Pignon, J. Bourhis, C. Hill, 2001 .

Glucagon-like peptide-2 improves both acute and late experimental radiation enteritis in the rat.

J. Bourhis, L. Thim, F. Milliat, 2007, International journal of radiation oncology, biology, physics.

Rapid tumor cell proliferation after induction chemotherapy in oropharyngeal cancer

J. Bourhis, G. Wilson, J. Bosq, 1994, The Laryngoscope.

Total body irradiation versus busulfan based intermediate intensity conditioning for stem cell transplantation in ALL patients >45 years—a registry-based study by the Acute Leukemia Working Party of the EBMT

J. Bourhis, M. Labopin, P. Chevallier, 2023, Bone Marrow Transplantation.

A phase II randomized trial of pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced (LA) squamous cell carcinoma of the head and neck (SCCHN): First results of the GORTEC 2015-01 “PembroRad” trial.

J. Bourhis, J. Prevost, C. Sire, 2018 .

The Insulin-Like Growth Factor 1 Receptor: A Target for Cancer Treatment

J. Bourhis, Y. Tao, E. Deutsch, 2007 .

The olivacine S16020 enhances the antitumor effect of ionizing radiation without increasing radio-induced mucositis.

J. Bourhis, L. Maggiorella, V. Frascogna, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Predictive assays of radiation response in patients with head and neck squamous cell carcinoma: a review of the Institute Gustave Roussy experience.

J. Bourhis, G. Wilson, F. Eschwège, 1997, International journal of radiation oncology, biology, physics.

Results of 2 meta-analyses on the role of chemotherapy (CT) in head and neck squamous cell carcinoma (HNSCC)

J. Bourhis, Christian Domenge, M. Luboinski, 1998 .

Antiangiogenic effect and tumor growth control achieved by an MMP-inhibitor combined to radiation in vivo, targeting radio-induced MMP-2 enhancement and VEGF modulation

C. Haie-meder, P. Opolon, J. Bourhis, 2004 .

Rescue procedure for an electrical storm using robotic non-invasive cardiac radio-ablation.

J. Bourhis, J. Schwitter, M. Zeverino, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

P73 Oral cavity squamous cell carcinoma in 260 patients aged 80 years or more

R. Arriagada, J. Bourhis, A. Italiano, 2009 .

IMRT or conformal radiotherapy for adjuvant treatment of retroperitoneal sarcoma?

J. Bourhis, D. Lefkopoulos, S. Bonvalot, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Optimization of Alanine Measurements for Fast and Accurate Dosimetry in FLASH Radiation Therapy

J. Bourhis, F. Bochud, R. Moeckli, 2020, Radiation Research.

Isodose 20 Gy found as a threshold dose for radiation recall dermatitis

J. Bourhis, M. Ozsahin, M. Vozenin, 2019, Clinical and translational radiation oncology.

Oral Cavity, Pharynx, and Larynx Cancer

J. Bourhis, 2006 .

Determination of the effective dose delivered by image guided radiotherapy in head & neck and breast treatments.

J. Bourhis, F. Bochud, R. Moeckli, 2018, Zeitschrift fur medizinische Physik.

Allogeneic Hematopoietic Cell Transplantation in AML with Normal Karyotype and NPM1 Mutated FLT3-ITD Negative: A Retrospective Analysis from the Acute Leukemia Working Party of EBMT

J. Esteve, J. Bourhis, M. Labopin, 2014 .

Survival Improvement in Therapy Related Myeloid Neosplasm ? a Single Center Analysis of 428 Patients

J. Bourhis, E. Solary, S. Koscielny, 2016 .

Network-meta-analysis of chemotherapy in nasopharyngeal carcinoma (MAC-NPC): An update on 8,221 patients.

Jun Ma, J. Pignon, J. Bourhis, 2020 .

Curative management of a cardiac metastasis from lung cancer revealed by an electrical storm

J. Bourhis, J. Schwitter, M. Zeverino, 2019, Clinical and translational radiation oncology.

Correlation between p53 gene expression and tumor-cell proliferation in oropharyngeal cancer.

J. Bourhis, G. Wilson, J. Bosq, 1994, International Journal of Cancer.

Very accelerated radiation therapy: preliminary results in locally unresectable head and neck carcinomas.

J. Bourhis, A. Fortin, J. Armand, 1995, International journal of radiation oncology, biology, physics.

TPExtreme randomized trial: TPEx versus Extreme regimen in 1st line recurrent/metastatic head and neck squamous cell carcinoma.

J. Bourhis, A. Aupérin, R. Mesía, 2015 .

[Indications and follow-up for autologous hematopoietic stem cell transplantation in autoimmune and autoinflammatory diseases: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

P. Vermersch, J. Bourhis, I. Yakoub-Agha, 2017, Bulletin du Cancer.

Stereotactic body radiotherapy with helical TomoTherapy for medically inoperable early stage primary and second-primary non-small-cell lung neoplasm: 1-year outcome and toxicity analysis.

J. Bourhis, C. Beigelman-Aubry, A. Lovis, 2015, The British journal of radiology.

Difference in performance between 3D and 4D CBCT for lung imaging: a dose and image quality analysis

Pascal Monnin, François Bochud, Raphaël Moeckli, 2016, Journal of applied clinical medical physics.

Preliminary results of the GORTEC 96-01 randomized trial, comparing very accelerated radiotherapy versus concomitant radio-chemotherapy for locally inoperable HNSCC

J. Bourhis, A. Aupérin, P. Verrelle, 2001 .

Relationship between pneumonitis induced by immune checkpoint inhibitors and the underlying parenchymal status: a retrospective study

John O. Prior, J. Bourhis, C. Beigelman-Aubry, 2020, ERJ Open Research.

Chemo-radiotherapy in head and neck cancer.

J. Bourhis, S. Temam, J. Guigay, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Dose indicator for CyberKnife Image-Guided Radiation Therapy.

J. Bourhis, F. Bochud, L. Schiappacasse, 2020, Medical physics.

Very accelerated versus conventional radiotherapy in HNSCC: Results of the GORTEC 94-02 randomized trial

J. Bourhis, F. Eschwège, N. Daly-Schveitzer, 2000 .

LUX head and neck 2: A randomized, double-blind, placebo-controlled, phase III study of afatinib as adjuvant therapy after chemoradiation in primarily unresected, clinically high-risk, head and neck cancer patients.

J. Bourhis, E. Cohen, B. Burtness, 2012 .

[18F]FDG-PET/CT metabolic parameters as useful prognostic factors in cervical cancer patients treated with chemo-radiotherapy

John O. Prior, J. Bourhis, M. Ozsahin, 2016, Radiation oncology.

Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma.

J. Bourhis, G. Wilson, G. Riou, 1991, Cancer research.

Accelerated versus Conventional Radiotherapy with Concomitant Chemotherapy in Locally Advanced Head and Neck Carcinomas: Results of a Phase III Randomized Trial

V. Grégoire, G. Calais, J. Bourhis, 2008 .

Double-blind randomized phase II results comparing concurrent high-dose cisplatin chemorradiation (CRT) plus debio 1143 or placebo in high-risk patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN): A GORTEC study

J. Bourhis, F. Clatot, C. Sire, 2019, Annals of Oncology.

[Proton therapy for head and neck squamous cell carcinomas: From physics to clinic].

J. Bourhis, M. Vidal, J. Thariat, 2019 .

A metastatic relapse associated with hippocampal dose sparing after whole-brain radiotherapy

R. Mirimanoff, J. Bourhis, L. Schiappacasse, 2015, Acta oncologica.

Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.

M. van Glabbeke, J. Bourhis, M. Bolla, 2004, The New England journal of medicine.

Tyrphostin AG 1024 modulates radiosensitivity in human breast cancer cells

J. Bourhis, L. Maggiorella, N. Chavaudra, 2001, British Journal of Cancer.

British Journal of Cancer

J. Bourhis, L. Maggiorella, N. Chavaudra, 2001 .

Intensity-modulated radiation therapy (IMRT): toward a new standard for radiation therapy of head and neck cancer?

J. Bourhis, N. Daly-Schveitzer, Y. Tao, 2011, European annals of otorhinolaryngology, head and neck diseases.

Improving safety in radiotherapy: the implementation of the Global Risk Analysis method.

Dimitri Lefkopoulos, Eric Deutsch, Renaud Mazeron, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[(18)F]FDG-PET standard uptake value as a metabolic predictor of bone marrow response to radiation: impact on acute and late hematological toxicity in cervical cancer patients treated with chemoradiation therapy.

John O. Prior, J. Bourhis, M. Ozsahin, 2013, International journal of radiation oncology, biology, physics.

A retrospective analysis of the outcome of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck refractory to a platinum-based chemotherapy.

R. Stupp, J. Bourhis, R. Hitt, 2005, Clinical oncology (Royal College of Radiologists (Great Britain)).

Comparison of Reduced Intensity Conditioning - Allogeneic HCT and Autologous HCT for Elderly Patients with Acute Lymphoblastic Leukemia. an Analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

J. Bourhis, M. Labopin, I. Yakoub-Agha, 2020 .

Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)

M. van Glabbeke, J. Jacobs, J. Bourhis, 2005, Head & neck.

Carfilzomib, lenalidomide and dexamethasone followed by a second ASCT is an effective strategy in first relapse multiple myeloma: a study on behalf of the Chronic malignancies working party of the EBMT.

J. Bourhis, I. Yakoub-Agha, D. Mclornan, 2023, Bone marrow transplantation.

Summary of the Standards, Options and Recommendations for nutritional support in patients undergoing bone marrow transplantation (2002)

J. Bourhis, P. Bachmann, J. Desport, 2003, British Journal of Cancer.

Absent benefit of accelerated concomitant chemoradiotherapy – Authors' reply

J. Bourhis, C. Sire, P. Blanchard, 2012 .

Microvascular leakage and contrast enhancement as prognostic factors for recurrence in unfavorable low-grade gliomas

K. Hoang-Xuan, J. Bourhis, C. Lacroix, 2010, Journal of Neuro-Oncology.

Poster: Clinical track: Treatment preparation and deliveryPO-0799: Normal brain, neural stem cells and glioblastoma responses to FLASH radiotherapy

J. Bourhis, F. Bochud, V. Favaudon, 2015 .

Characteristics of very high-energy electron beams for the irradiation of deep-seated targets.

J. Bourhis, F. Bochud, R. Moeckli, 2021, Medical physics.

[18F]FDG-PET/CT metabolic parameters as useful prognostic factors in cervical cancer patients treated with chemo-radiotherapy

John O. Prior, J. Bourhis, M. Ozsahin, 2016, Radiation Oncology.

J. Bourhis, I. Yakoub-Agha, P. Moreau, 2006, Blood.

Donor Lymphocyte Infusions After Allogeneic Transplantation: A Single-Center Experience.

J. Bourhis, E. Solary, T. Coman, 2019, Clinical lymphoma, myeloma & leukemia.

Hepatic veno-occlusive disease after myeloablative treatment and bone marrow transplantation: value of gray-scale and Doppler US in 100 patients.

J. Bourhis, J. Bosq, A. Roche, 1997, Radiology.

Neoadjuvant chemoradiotherapy delivered with helical tomotherapy under daily image guidance for rectal cancer patients: efficacy and safety in a large, multi-institutional series

J. Bourhis, M. Zeverino, M. Montemurro, 2019, Journal of Cancer Research and Clinical Oncology.

Hepatobiliary scintigraphy allows the evaluation of short-term functional toxicity of liver stereotactic body radiotherapy: Results of a pilot study

J. Bourhis, M. Zeverino, R. Moeckli, 2018, PloS one.

Role of Functional Imaging in Treatment Plan Optimization of Stereotactic Body Radiation Therapy for Liver Cancer

John O. Prior, J. Bourhis, M. Zeverino, 2016, Tumori.

Should we include SPECT lung perfusion in radiotherapy treatment plans of thoracic targets? Evidences from the literature.

John O. Prior, J. Bourhis, M. Ozsahin, 2016, Critical reviews in oncology/hematology.

Role of cancer treatment in long-term overall and cardiovascular mortality after childhood cancer.

J. Bourhis, D. Lefkopoulos, F. de Vathaire, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[Squamous cell carcinoma of the hypopharynx and larynx: evidence-based care].

J. Bourhis, J. Fayette, Y. Pointreau, 2014, Bulletin du cancer.

Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis

K. Ang, J. Horiot, J. Pignon, 2006, The Lancet.

J. Bourhis, A. Hagemeijer, F. Mandelli, 2003, Blood.

Improved Outcome by Adding Concurrent Chemotherapy to Cetuximab and Radiotherapy for Locally Advanced Head and Neck Carcinomas: Results of the GORTEC 2007-01 Phase III Randomized Trial.

J. Bourhis, C. Borel, P. Maingon, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

PET-based prognostic survival model after radiotherapy for head and neck cancer

John O. Prior, J. Bourhis, O. Acosta, 2018, European Journal of Nuclear Medicine and Molecular Imaging.

Randomized phase III trial comparing induction chemotherapy using cisplatin (P) fluorouracil (F) with or without docetaxel (T) for organ preservation in hypopharynx and larynx cancer. Preliminary results of GORTEC 2000-01.

J. Bourhis, C. Sire, J. Tortochaux, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

JC human polyomavirus is associated to chromosomal instability in peripheral blood lymphocytes of Hodgkin's lymphoma patients and poor clinical outcome.

J. Bourhis, L. Andréoletti, R. M’kacher, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma.

V. Grégoire, J. Bourhis, M. Hamoir, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

J. Bourhis, I. Yakoub-Agha, D. Blaise, 2012, Haematologica.

Current incidence, severity, and management of veno-occlusive disease/sinusoidal obstruction syndrome in adult allogeneic HSCT recipients: an EBMT Transplant Complications Working Party study

J. Bourhis, M. Mohty, U. Salmenniemi, 2023, Bone Marrow Transplantation.

High Z nanoparticles and radiotherapy: a critical view.

J. Bourhis, R. Jumeau, F. Vilotte, 2019, The Lancet. Oncology.

[Chemoradiation for oesophageal cancer: A critical review of the literature].

J. Bourhis, P. Maingon, M. Ozsahin, 2019, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Outcome of patients with distinct molecular genotypes and cytogenetically normal AML after allogeneic transplantation.

J. Esteve, J. Bourhis, F. Baron, 2015, Blood.

The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis.

A. Hart, H. Bartelink, J. Horiot, 1999, Radiotherapy and Oncology.

[Measurement of the kinetics of cell proliferation of cancer of the oropharynx in vivo by the incorporation of bromodeoxyuridine and flow cytometry].

J. Bourhis, G. Wilson, N. Chavaudra, 1991, Bulletin du Cancer.

[Locally advanced head and neck cancers: recommendations of an expert panel and perspectives for the use of TPF regimen (docetaxel, cisplatin and fluoro-uracil) as induction therapy].

J. Bourhis, G. Milano, S. Hans, 2009, Bulletin du cancer.

Preclinical assessment of JNJ-26854165 (Serdemetan), a novel tryptamine compound with radiosensitizing activity in vitro and in tumor xenografts.

Cyrus Chargari, J. Bourhis, M. Janicot, 2011, Cancer letters.

Discrepancies between selected Pareto optimal plans and final deliverable plans in radiotherapy multi-criteria optimization.

Kristoffer Petersson, François Bochud, Marc Pachoud, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Scoring System Based on Post-Transplant Complications in Patients after Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome: A Study from the SFGM-TC.

J. Bourhis, M. Robin, P. Chevallier, 2019, Current research in translational medicine.

EP-1179: Extraction of pulmonary emphysema structure with Myrian© software and transfer to the radiotherapy planning system

J. Bourhis, C. Beigelman, R. Moeckli, 2015 .

Can Stereotactic Body Radiotherapy Really Be Considered the Preferred Treatment in Large Hepatocellular Carcinoma?

J. Bourhis, M. Ozsahin, G. Deplanque, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

New techniques in radiation therapy for head and neck cancer: IMRT, CyberKnife, protons, and carbon ions. Improved effectiveness and safety? Impact on survival?

J. Bourhis, J. Thariat, P. Marcy, 2011, Anti-cancer drugs.

Influence of Nucleoshuttling of the ATM Protein in the Healthy Tissues Response to Radiation Therapy: Toward a Molecular Classification of Human Radiosensitivity.

J. Bourhis, D. Stoppa-Lyonnet, A. Puisieux, 2016, International journal of radiation oncology, biology, physics.

Allogeneic vs autologous stem cell transplantation according to cytogenetic features in AML patients (pts) <= 45 yrs old in first CR: Results of the EORTC-GIMEMA AML-10 trial

J. Bourhis, F. Mandelli, R. Willemze, 2001 .

J. Bourhis, C. Craddock, M. Labopin, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Interfractional set-up errors evaluation by daily electronic portal imaging of IMRT in head and neck cancer patients

R. Arriagada, J. Bourhis, D. Lefkopoulos, 2009, Acta oncologica.

Phase I Trial of Debio 1143, an Antagonist of Inhibitor of Apoptosis Proteins, Combined with Cisplatin Chemoradiotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck

J. Bourhis, Y. Tao, V. Calugaru, 2020, Clinical Cancer Research.

TPExtreme randomized trial: Quality of Life (QoL) and survival according to second-line treatments in patients with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC).

J. Bourhis, C. Sire, A. Aupérin, 2020 .